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Orofacial clefting (OFC) is among the most common congenital craniofacial 
defects in humans, with a frequency of about 8 per 10,000 live births worldwide 
which is highest in Asian and lowest in African populations 1. Depending on 
their severity, OFC can cause a wide range of functional problems pertaining to 
eating, hearing, speaking and swallowing, as well as psychosocial problems due 
to facial scars and dental abnormalities 2, 3. OFC requires a multidisciplinary 
treatment including several surgical interventions from early childhood until 
adulthood 4. Due to its incidence, morbidity, and the complex treatment, it is 
crucial to better understand the aetiology of OFC.  
 
Figure 1. Anatomical subtypes of orofacial clefting. A, (unilateral) cleft lip; B, (unilateral) cleft lip, 
alveolus and palate; C, (bilateral) cleft lip, alveolus and palate; D, Isolated cleft palate.  
Source: http://www.biomedcentral.com/content/figures/1471-2350-5-15-1.jpg 
 
Anatomically, OFC can be divided into isolated cleft lip and/or alveolus, isolated 
cleft palate, and combined cleft lip, alveolus, and palate which can be further 
subdivided into complete or incomplete, and unilateral or bilateral clefts (Figure 
1). Developmentally, OFC can occur as an isolated defect or within a syndrome, 
thus classified as non-syndromic and syndromic OFC respectively. The aetiology 
of OFC is complex and includes both genetic and environmental factors.  
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Palatogenesis 
In humans, the face starts to develop in the fourth week of embryogenesis from 
the facial primordia which consist of the (single) frontonasal prominence, the 
paired maxillary prominences and the paired mandibular prominences 5 (Figure 
2). Together these prominences surround the stomodeum (the primitive oral 
cavity). The facial primordia consist of neural crest-derived mesenchyme (which 
will give rise to the facial skeleton) and the mesodermal core (which will give 
rise to facial muscles) covered with ectoderm 6-8. Because the fusion of the 
different facial primordia in the midface requires a precise spatiotemporal 
regulation, any disruption in the regulatory network can result in OFC. 
 
 
Figure 2. Frontal view of heads of human embryo 4 and 5 weeks of age.          
Adapted from: http://clinicalgate.com/head-and-neck-6/ 
 
Due to the similarity to human palatogenesis and  the ethical limitations for 
research with human embryos, most of the knowledge on palate development 
has been obtained from mouse studies. The overview presented here is, 
therefore, based mainly on mouse studies.  
On the 12th day of mouse embryogenesis and in the 6th week of human 
embryogenesis, the palate starts to develop from a single median palatine 
process in the front and two paired lateral palatine processes sideways, further 
referred to as the palatal shelves. As it develops, the median palatine process 
will form the primary palate and the palatal shelves will fuse and form the 
secondary palate. The secondary palate develops in ordered stages of the palatal 
shelf outgrowth, elevation, adhesion and fusion following disintegration of the 
midline epithelial seam (MES) (Figure 3). Initially, the palatal shelves grow 
5 
 
vertically adjacent to the developing tongue. As the mandible develops allowing 
the tongue to descend,  the palatal shelves reorient to the horizontal position 
above the tongue and start to grow towards the midline. At the midline, they 
adhere to each other and form the MES. Subsequently, the MES disappears to 
allow mesenchymal confluence throughout the secondary palate. Finally, the 
secondary palate fuses anteriorly to the primary palate and anterodorsally to the 
nasal septum, thus separating the oral cavity from the nasal cavity. 
Palatogenesis is completed by the 16th day of mouse embryogenesis and by the 
12th week of human embryogenesis 9-11. Eventually, the neural crest-derived 
anterior part of the secondary palate will undergo intramembranous ossification 
and will form the hard palate, whereas the paraxial mesoderm-derived posterior 
part will undergo myogenesis and form the soft palate 12.  
 
Failure of palatogenesis  
OFC can occur as a result of failure in one or more stages of palate development, 
i.e.  (1) failure of palatal shelf outgrowth, (2) fusion of the palatal shelves with 
the tongue or the mandible, (3) failure of palatal shelf elevation, (4) failure of 
the palatal shelves to adhere to each other, and (5) persistence of the MES 7. 
Secondarily, persistence of the tongue due to mandibular underdevelopment 
can obstruct palatal shelf elevation and lead to OFC 13. Cellular processes such as 
proliferation, differentiation, adhesion, migration and apoptosis, as well as their 
precise spatiotemporal regulation are crucial events in various stages of 
palatogenesis.  
 
1. Failure of palatal shelf outgrowth 
Palatal shelves consist of NCC-derived mesenchyme covered with oral 
epithelium and their development depends on ectomesenchymal cell 
proliferation. Reduced proliferation of both epithelial and mesenchymal cells 
can prevent sufficient outgrowth of the palatal shelves. Proliferation of palatal 
epithelial and mesenchymal cells is (mainly) under regulation of the Wnt, Fgf, 
Shh, Tgfβ, Bmp and Notch signalling pathways. Disruption of canonical Wnt 
signalling through inactivation of its ligand Wnt9b or receptor Lrp6 results in 
14 | Chapter 1
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reduced ectomesenchymal cell proliferation. Also disruption of Shh signalling 
through inactivation of its receptors patched1 (Ptch1) and smoothened (Smo) in 
mice decreases proliferation of both palatal mesenchyme and epithelium which 
results in insufficient palatal shelf outgrowth (Table 1). 
 
 
Figure 3. Palatogenesis in mouse.  
A-E, scanning electron micrographs (SEM) showing oral views of the developing mouse secondary palate 
corresponding to each developmental stage. Orange lines mark sites of fusion between the medial nasal 
processes and maxillary processes, white arrowheads point to initial outgrowths of the primary palate, 
white arrows point to the initial outgrowth of the palatal shelves (PS), red arrowheads mark the initial 
site of palatal adhesion and fusion, and the yellow arrowhead points to the gap between the primary and 
secondary palates that will eventually disappear. F-G, representative histological sections from the 
anterior region of the developing palate at each indicated stage. At E11.5 (A, F), the PS develop from the 
oral surface of the maxillary processes. At E13.5 (B, G), the PS grow downward along the tongue. E14.5 
(C, H), the PS have elevated to the horizontal position. At ~E15.0 (D, I), the PS make contact at the 
midline and initiate adhesion by formation of the midline epithelial seam (MES). By E15.5 (E, J), PS 
fusion is visible following disintegration of the MES. Remnants of the MES can still be seen at this stage 
and the palatal shelves also fuse dorsally with the nasal septum (J).  
Abbreviations: E, embryonic day; MdbP, mandibular process; MNP, medial nasal process; MxP, 
maxillary process; NS, nasal septum; PP, primary palate; PS, palatal shelf; SP, secondary palate; T, 
tongue. Adapted from 9. 
 
2. Fusion of the palatal shelves with the tongue or the mandible  
The epithelium of the embryonic oral cavity is lined with the periderm, a layer 
of flattened epithelial cells 14, which provides a non-sticking barrier to prevent 
aberrant epithelial adhesions 15. Prior to adhesion of the palatal shelves, these 
periderm cells disappear through apoptosis 16, 17 and possibly also through 
migration to the oral and nasal side of the palatal shelves 18, 19 exposing the 
midline epithelial edge (MEE) cells. Impaired peridermal differentiation, as well 
as impaired peridermal desquamation might cause abnormal fusions of palatal 
7 
 
shelves to the tongue or the mandible. That is, inactivation of ΔNp63, Irf6 and 
Notch ligand Jagged 2 impairs peridermal differentiation and leads to premature 
fusions  14, 16, 20, whereas inactivation of Tgfβ3 impairs periderm apoptosis and 
hampers the MES formation 16 (Table 1). 
 
3. Failure of palatal shelf elevation 
To date, the exact mechanism of palatal shelf elevation is not clear. Two driving 
mechanisms are commonly accepted: intrinsic and extrinsic factors. Intrinsic 
factors include extracellular matrix (ECM) components which contribute to the 
volume of the palatal shelves and might act as driving force for horizontal 
reorientation 21. Extrinsic factors include downward displacement of the tongue 
following the mandibular growth spurt 21. Deviations in the expression of ECM 
components, as well as deviations in the mandibular growth rate followed by 
delayed tongue displacement might obstruct palatal shelf elevation. Disruption 
of Wnt signalling through inactivation of R-spondin2, disruption of Fgf 
signalling through inactivation of Fgf8, Fgf10 and Fgf receptors 1 and 2 (Fgfr1 and 
Fgfr2), as well as disruption of Bmp signalling through inactivation of Bmp2 and 
Bmp receptor 1a (Bmpr1a) decreases proliferation and increases apoptosis in 
mandibular mesenchyme. This results in mandibular underdevelopment and 
persistence of the tongue between the palatal shelves which results in OFC. 
Furthermore, premature fusions of the palatal shelves to the tongue or mandible 
can hamper horizontal reorientation of the palatal shelves (Table 1).  
 
4. Failure of the palatal shelves to adhere 
Following periderm desquamation and just before fusion, the surface of the 
opposing palatal shelf epithelia differentiate into bulging cells 22, 23 and develop 
lamellipodia and filopodia 24, 25. These microstructures might facilitate the 
adhesion, possibly, through physical interlocking which prevents sliding 
between opposing epithelia. Interestingly, the palatal epithelia of mice lacking 
Tgfβ3 or Tgfβ receptor 1 (Tgfbr1) do not differentiate into bulging cells and do 
not develop filopodia which results in failure of the palatal shelves to adhere 22-
24, 26 (Table 1). 
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5. Persistence of the MES 
As soon as the palatal shelves make contact at the midline, the midline 
epithelial seam (MES) is formed. Subsequently, the MES should disappear to 
allow mesenchymal continuity across the palate. The fate of the MES has been 
explained by three mechanisms: (1) epithelial-mesenchymal transition, (2) 
migration to the oral or nasal side of the palate and (3) apoptosis 25, 27. Recent 
evidence shows that the MES disappear mainly through apoptosis 17, 28, although 
involvement of one or both of the two other suggested mechanisms cannot be 
entirely excluded. Disruption of Tgfβ signalling through inactivation of Tgfβ3 
and its receptors Tgfbr1 and Tgfbr2  reduces apoptosis within the MES and 
results in MES persistence (Table 1).  
In summary, specific cellular functions, as well as their correct spatiotemporal 
regulation are crucial for palatogenesis. Accordingly, any deviations in the 
regulation of these cellular processes might impair palatogenesis and lead to 
OFC. Table 1 summarizes the major pathways in the pathogenesis of OFC.  
 
Etiopathogenesis of syndromic OFC 
Most of the current knowledge on the genetic background of OFC has been 
obtained from studies on syndromic forms, which constitute 5-7% of all cases 2. 
OFC is the primary feature of at least 275 syndromes 29. Syndromic OFC is 
caused by mainly chromosomal abnormalities, as well as single gene mutations. 
Many of these genes encode developmentally important transcription factors, 
growth factors and other regulatory factors. For instance, mutations in specific 
genes such as IRF6, GRHL3, TP63, PVRL1 and several others underlie syndromic 
forms of OFC 3. 
IRF6, encoding the transcription factor interferon regulatory factor 6, is one of 
the most studied genes in the pathogenesis of syndromic OFC. Mutations in this 
gene give rise to Van der Woude syndrome and popliteal pterygium syndrome 
30, which are the most common syndromic forms of OFC. Recently, novel 
mutations in IRF6 were found to cause also non syndromic OFC 31, 32. Studies in 
9 
 
mice demonstrate that Irf6 is a key regulator of keratinocyte proliferation and 
differentiation during embryonic development. Mutations in Irf6 in mice cause 
aberrant epithelial adhesions because keratinocytes fail to undergo terminal 
differentiation and continue to proliferate. Abnormal adhesions of the palatal 
shelves to the tongue and the mandible leads to clefting 33, 34. Moreover, IRF6 
initiates periderm formation and maintains its integrity through the 
Jagged2/Notch1 pathway in order to prevent premature epithelial adhesions 14, 20. 
Interestingly, IRF6 appears to be a direct target of p63 35, 36, which is another 
well-known risk factor for  syndromic OFC. 
GRHL3 is the second gene identified as the causative factor for Van der Woude 
syndrome 37. Grhl3 is downstream of Irf6 and is required for periderm 
differentiation both in zebrafish and in mouse 38, 39. Proper periderm 
differentiation is required to prevent aberrant adhesions of palatal epithelium 
with other intraoral structures 15. In addition, variants of GRHL3 gene have been 
associated with non-syndromic OFC 38, 40, 41. 
Mutations in TP63 encoding the transcription factor p63, underlie a group of 
syndromes characterized by various combinations of ectodermal dysplasia, OFC 
and limb malformations 42, 43, as well as non-syndromic forms of OFC 44. In mice, 
ablation of Tp63 causes severe epidermal, limb and craniofacial defects and 
these animals die shortly after birth 45, 46. These mice lack all stratified epithelia 
including epidermis and oral epithelia, which demonstrates the crucial role of 
p63 in epidermal commitment and differentiation. In vitro studies on mouse 
embryonic stem cells showed that p63 regulates epidermal commitment as well 
as epithelial stem cell proliferation and renewal 47, 48. p63 is highly expressed in 
the epithelium of the palatal shelves 49, and regulates periderm differentiation 16, 
28. Defective periderm differentiation can disturb palate development through 
premature adhesion of the palatal shelves with other intraoral structures 16.  
Hence, p63 is a key regulator of peridermal and oral epithelial differentiation.  
Sox9 is the key regulator of the neural crest-derived vertebrate craniofacial 
skeleton 50 and dysregulation of SOX9 gives rise  to Pierre Robin sequence (PRS, 
OMIM # 261800) 51, which is a severe craniofacial anomaly characterized by 
OFC, micrognathia and glossoptosis (downward and backward displacement of 
the tongue). PRS can be lethal due to respiratory and feeding difficulties in the 
newborn 52. Both heterozygous and homozygous mutations of Sox9 cause OFC 
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in mice, in fact, the latter causes a lethal cleft because of respiratory distress 53, 
54.  
A mutation in PVRL1, encoding cell adhesion molecule nectin-1, causes an 
autosomal recessive ectodermal dysplasia (CLPED1) characterized by OFC, 
syndactyly, and ectodermal dysplasia 55. Along with IRF6, GRHL3, TP63, SOX9  
and PVRL1, mutations in several other genes have been identified as causative 
factors for syndromic OFC. Specific mutations and OFC subtypes caused by 
these mutations are discussed in detail elsewhere 3.  
 
Etiopathogenesis of non-syndromic OFC  
The combination of genetic risk factors with environmental exposure can 
underlie the pathogenesis of non-syndromic OFC. In general, morphogenesis is 
strongly affected by the genetic background of the embryo as well as the 
mother. The genetic background includes transcription factors, growth factors 
and other regulatory molecules that orchestrate gene expression and signal 
transduction during morphogenesis. Environmental factors, on the other hand, 
include maternal nutrition, smoking, alcohol consumption, exposure to drugs 
and ionizing radiation. 
 
Molecular pathogenesis of non-syndromic OFC 
Secondary palate development is under tight control of several major signalling 
pathways. For instance, the Wnt signalling regulates cell proliferation, 
migration and apoptosis during palatogenesis and certain perturbations of Wnt 
signalling cause OFC both in humans and in mice 56-62. Disruption of canonical 
Wnt signalling in mice reduces the proliferation of palatal ectomesenchyme and 
thereby impairs palatal shelf outgrowth and elevation (Table 1). Moreover, 
disruption of canonical Wnt signalling  reduces the apoptosis of MES cells 
through down-regulation of Tgfβ3, which results in impaired adhesion of the 
palatal shelves and persistence of the MES (Table 1). 
The Fgf signalling regulates cell proliferation, differentiation and survival during 
palate development. Mutations in Fgf pathway give rise to craniosynostosis and 
11 
 
OFC 12, 63-66. Studies in mice have shown that inactivation of Fgf8, Fgf10 or their 
receptors Fgfr1 and Fgfr2 results in reduced proliferation of palatal 
ectomesenchyme which disturbs palatal shelf outgrowth and elevation (Table 1).  
The Shh signalling is also indispensible for craniofacial morphogenesis, 
including palate development 67, 68. It regulates the proliferation of palatal 
ectomesenchyme, as well as the apoptosis of MES cells. Shh acts upstream of 
canonical Wnt and p63/Irf6 signalling. Mutations in the Shh receptor patched 1 
in mice downregulate canonical Wnt signalling and p63/Irf6 signalling leading 
to decreased apoptosis and increased proliferation of MES cells. This results in 
MES persistence and failure of palatal fusion (Table 1).  
Aberrant Tgfβ signalling is associated to both syndromic and non-syndromic 
OFC.  Mutations in TGFBR2 causes Loeys-Dietz syndrome in humans, displaying 
OFC as one of the main features 69. In mice, ablation of Tgfb2 results in wide 
OFC 70 and ablation of Tgfbr2 causes a cleft secondary palate, a cleft soft palate, 
and a failure of the primary palate to fuse with the secondary palate 71-73. 
Impaired Tgfβ signalling results in reduced apoptosis of periderm cells, reduced 
differentiation of palatal epithelium and filopodia formation, and reduced 
apoptosis of MES. This leads to impaired palatal shelf adhesion, persistence of 
MES and failure of palatal fusion (Table 1).  
Downstream of the Tgfβ pathway, the Bmp signalling is required for lip and 
palate development 74-78. Perturbation of Bmp signalling through inactivation of 
Bmp2, Bmp4 or Bmpr1a in mice decreases the proliferation and differentiation 
of palatal mesenchyme. This leads to reduced palatal shelf outgrowth and 
elevation, and also impairs bone formation in the palate (Table 1).  
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Table 1. Molecular pathogenesis of OFC 
Pa
th
w
ay
 
Loss of 
function 
mutations 
Gene interactions Affected cellular processes Affected stages of palatogenesis 
Refe-
rences 
Ca
no
ni
ca
l W
N
T 
Wnt9b 
↓ Fgf8, Fgf10, Fgf17 
↓ Msx1, Msx2 
↑Raldh3 
↓ proliferation of palatal 
mesenchyme Palatal shelf outgrowth 
79 
Rspo2 ↓ Msx1, Msx2 
↓ Fgf8, Bmp4 
↑ apoptosis in mandible and 
tongue mesenchyme Palatal shelf elevation 
13 
β-catenin 
↓ Shh, Ptch1 
Disturbed proliferation 
orientation (↓ AP growth, ↑ 
ML growth) 
Rugae formation 
AP palatal shelf 
outgrowth 
80 
↓ Tgfβ3 
↓ Proliferation of palatal 
epithelium 
↓ apoptosis of the MES cells 
MES disintegration 
Palatal fusion 
81* 
Lrp6 ↓ Msx1, Msx2 
↑ Raldh3 
↓ proliferation of palatal 
mesenchyme Palatal shelf outgrowth 
82 
N
on
-c
an
on
ic
al
 
W
N
T  Wnt5a 
↓ Bmp4, Shh, Msx1 
in anterior  
↑ Bmp4, Shh in 
posterior 
↓ migration of palatal 
mesenchymal cells Palatal shelf outgrowth 
83 
Wnt11 ↑ Fgfr1 ↓ apoptosis of the MES cells Palatal shelf fusion 84* 
FG
F 
Fgfr1,  
Fgfr2 
↑ Notch1, Bmp4 
↓ Wnt1, Tgfβ3, Shh 
↓ proliferation of palatal 
epithelium & mesenchyme  
↓ apoptosis of MES cells 
Palatal shelf elevation 
Palatal shelf fusion 
Rugae formation 
85-87 
Fgf 8 ↑ Shh, Fgf10, Fgf7, Dlx5, Osr2 
↓ proliferation palatal 
mesenchyme 
↑ proliferation of palatal 
epithelium 
Palatal shelf outgrowth 
Palatal shelf elevation 
88* 
Fgf10 ↓ Jagged2 
↑ Tgfβ3 
↑ apoptosis of anterior MEE 
cells  
↑ premature adhesion to the 
mandible 
Palatal shelf elevation 89 
Fgf10/ 
Fgfr2b ↓ Shh 
↓ proliferation of palatal 
epithelium & mesenchyme 
↓ survival of palatal epithelial 
cells 
Palatal shelf outgrowth 
Rugae formation 
90 
SH
H 
Ptch1 ↑ canonical WNT  
↑ p63/IRF6 
↓ apoptosis of MES cells 
↑ proliferation of MES cells Palatal shelf fusion 
28, 91* 
Smo 
↓ Ccnd1, Ccnd2 
↓ Bmp2, Fgf10 
↑ Bmp4, Msx1 
↓ Foxf1a, Foxf2 
↓ proliferation of palatal 
epithelium & mesenchyme Palatal shelf outgrowth 
80, 92, 93 
TG
Fβ
 
Tgfβ3 
 
↑ ΔNp63 
↑ β2 integrin 
↑EGF 
↓ CSPG 
↓FasL-Fas-caspase 
↓ apoptosis of periderm cells  
↑ proliferation of MEE  
↓ differentiation of MEE 
↓ filopodia formation 
↓ apoptosis of MES  
Palatal shelf adhesion  
Palatal shelf fusion 
 
16, 17, 22-
24, 94-99 
13 
 
Tgfbr1 ↓ Msx1 
↑ Fgf8 
↑ apoptosis of palatal 
mesenchyme  
↓ filopodia formation 
↓ apoptosis of MES  
Palatal shelf outgrowth 
Palatal shelf adhesion 
Palatal shelf fusion 
26 
Tgfbr2 
 
↓ Irf6 
↓FasL-Fas-caspase 
↑ proliferation of MEE 
↓ apoptosis of MES  Palatal shelf fusion  
71, 98 
↑ Msx1 ↓ proliferation of palatal mesenchyme Palatal shelf outgrowth 
72 
BM
P 
Bmp2 ↓ Tgfβ3 
↓ proliferation of palatal 
epithelium 
↓ apoptosis of palatal 
epithelium 
Palatal shelf outgrowth 
Palatal shelf elevation 
100* 
Bmp4 ↓ Tbx3 
↓ Shh, Bmp2 
↓ proliferation of palatal 
epithelium & mesenchyme 
Palatal shelf outgrowth 
 
93, 101 
Bmpr1a 
↓Msx1, Msx2 
↓ Pax9, Shox2 
↓ Bmp4, Shh  
↓ Fgf8, Fgf10, p63 
↓ proliferation of palatal 
mesenchyme 
↑ apoptosis of palatal 
mesenchyme 
↓ osteoblast differentiation  
Palatal shelf outgrowth 
Palatal shelf elevation 
Rugae formation 
Palatal ossification 
102-106 
N
ot
ch
 
Jagged 1  
↓ proliferation of palatal 
epithelium 
↓ ECM production 
↓ osteoblast differentiation & 
mineralization 
Palatal shelf outgrowth 
Palatal ossification 
107, 108 
Jagged 2/ 
Notch1 ↓ Fgfr2b 
↓ oral periderm 
differentiation 
↑ aberrant adhesion of palatal 
shelves to the tongue and the 
mandible 
Palatal shelf elevation 
 
20, 94, 109, 
110 
M
SX
 
Msx1  ↓ Bmp2, Bmp4, Shh  ↓ proliferation of palatal mesenchyme Palatal shelf outgrowth 
93 
Abbreviations and symbols: AP, anteroposterior; ML, mediolateral; Bmpr1a, BMP receptor type 1a; 
Ccnd1, Cyclin D1; Ccnd2, Cyclin D2; CSPG, chondroitin sulphate proteoglycan; Dlx5, Distal-less 
homeobox 5; ECM, extracellular matrix; Fgfr1, Ffg type 1 receptor; Fgfr2, Fgf type 2 receptor; Fox, 
Forkhead Box; Msx1, Msh homeobox 1; Osr2, Odd-skipped related-2; Pax9, paired box 9; Ptch1, patched1; 
Rspo2, R-spondin2; Shox2, Short Stature Homeobox 2; Smo, smoothened; Tbx3, T-box transcription 
factor 3; Tgfbr1, Tgfβ type 1 receptor; Tgfbr2, Tgfβ type 2 receptor; ↑, up-regulation / induction; ↓, down-
regulation / reduction; * gain of function / over-expression studies. 
 
Furthermore, the Notch and Msx1 signalling play important roles in 
palatogenesis 111-115. Certain mutations in these pathways lead to reduced palatal 
shelf outgrowth and elevation, as well as impaired palatal ossification in mice 
(Table 1).  
Together, these experimental data show that various signalling pathways are 
indispensible for palatogenesis, and that disruptions in these pathways result in 
Table 1 continued  
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Furthermore, the Notch and Msx1 signalling play important roles in 
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clefting. Table 1 summarizes the mechanism of some of these signalling 
pathways in the pathogenesis of OFC.  
 
Combination of genetic and environmental risk factors   
The aetiology of the majority of non-syndromic OFC cases is not clear, 
suggesting that it is a multifactorial disorder. In addition to genetic factors, 
numerous environmental factors such as drugs and medication, infections, 
metabolic disorders, nutrition, smoking and alcohol consumption as well as 
chemicals and ionizing radiation might contribute to the pathogenesis of non-
syndromic OFC 2, 3, 116.  
Daily, we are exposed to natural and synthetic chemicals with unknown impact 
on embryonic development and on adult body. Teratogenic effects of some of 
these environmental factors such as smoking or exposure to ionized radiation 
have been shown, whereas the effect of the majority is more subtle. Exposure to 
a certain environmental risk factor in combination with genetic susceptibility 
and the developmental stage can cause congenital birth defect(s). The 
interaction of environmental risk factors with genetic regulatory factors can 
disrupt signal transduction and eventually can impair cellular processes leading 
to developmental defect. Certain polymorphisms of, for instance, genes 
encoding metabolic enzymes of a vitamin can reduce the activity of that enzyme 
and eventually decrease the effective concentration of the vitamin. Therefore, it 
is crucial to better understand the mechanism of the interplay between 
environmental risk factors and genetic susceptibility. This will allow us to 
predict and eventually prevent the consequences of combined impact of genetic 
and environmental factors.  
Early embryogenesis, implantation and placentation are affected by maternal 
nutrition in the periconceptional period 117. In particular, micronutrients such as 
vitamins and minerals play crucial roles in the development of the embryo and 
their imbalance can give rise to severe congenital defects. For instance, folate is 
involved in DNA synthesis and cell division, and its periconceptional intake 
protects against neural tube defects, as well as OFC 116, 117. Numerous studies 
have shown that a folate-rich diet or folic acid (synthetic form of folate) 
supplementation before and during early pregnancy significantly reduces the 
15 
 
incidence of OFC in human offspring 118. Furthermore, various polymorphisms 
of folate metabolic enzymes have been found to increase the risk for OFC. For 
instance, several single nucleotide polymorphisms of methylenetetrahydrofolate 
reductase (MTHFR), a key enzyme in folate metabolism, have been shown to 
reduce the activity of the enzyme. Combined with deficient maternal folate 
intake, this can lead to increased risk of OFC in the offspring 119-124. Interestingly, 
a recent study shows that folic acid can reduce primary palate clefting in 
Xenopus induced by impaired vitamin A metabolism 125. Another essential 
micronutrient, lipid-soluble vitamin A, is of a particular importance during 
embryogenesis. It  cannot be synthesized by the human body either during 
embryogenesis or in adulthood. Therefore, maternal intake of vitamin A is the 
only source for the embryo. Vitamin A is available in meat in its precursor form  
retinyl palmitate and in yellow to red-pigmented plants in the form of 
carotenoids. Once ingested, both precursors will  be eventually converted to 
either retinoic acid or retinal, two physiologically active derivatives of vitamin A 
126. The most important derivative of vitamin A during embryogenesis is  
retinoic acid (RA) 126. Several polymorphisms of RA metabolic enzymes have 
been found to contribute to congenital neural tube, heart and gastrointestinal 
defects in humans 126. Interestingly, both deficiency and excess of RA give rise to 
severe craniofacial malformations, including OFC. The inactivation of RA 
signalling through deletion of its receptors RARα and RARγ in cranial neural 
crest cells results in agenesis of the midface including the secondary palate 127, 
128. In addition, high doses of RA  lead to severe malformations in all of the 
craniofacial region including cleft of the secondary palate 129, 130. Exactly how RA 
is involved in embryogenesis, in particular, its role in palatogenesis and the 
pathogenesis of OFC is unravelled in the following chapter.  
Although genes absolutely play a role in palate morphogenesis, gene-
environment interaction too is crucial and cannot be neglected. Therefore, this 
thesis is mainly focused on RA, an environmental risk factor for OFC 
pathogenesis. The studies within this project has been performed with oral 
keratinocytes obtained from OFC patients and control individuals. Our main 
goal was to study RA effects on oral keratinocytes and find indications on 
possible RA-related molecular and cellular mechanisms in OFC. In the next 
section, a short description of the individual studies from this thesis is 
presented. 
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clefting. Table 1 summarizes the mechanism of some of these signalling 
pathways in the pathogenesis of OFC.  
 
Combination of genetic and environmental risk factors   
The aetiology of the majority of non-syndromic OFC cases is not clear, 
suggesting that it is a multifactorial disorder. In addition to genetic factors, 
numerous environmental factors such as drugs and medication, infections, 
metabolic disorders, nutrition, smoking and alcohol consumption as well as 
chemicals and ionizing radiation might contribute to the pathogenesis of non-
syndromic OFC 2, 3, 116.  
Daily, we are exposed to natural and synthetic chemicals with unknown impact 
on embryonic development and on adult body. Teratogenic effects of some of 
these environmental factors such as smoking or exposure to ionized radiation 
have been shown, whereas the effect of the majority is more subtle. Exposure to 
a certain environmental risk factor in combination with genetic susceptibility 
and the developmental stage can cause congenital birth defect(s). The 
interaction of environmental risk factors with genetic regulatory factors can 
disrupt signal transduction and eventually can impair cellular processes leading 
to developmental defect. Certain polymorphisms of, for instance, genes 
encoding metabolic enzymes of a vitamin can reduce the activity of that enzyme 
and eventually decrease the effective concentration of the vitamin. Therefore, it 
is crucial to better understand the mechanism of the interplay between 
environmental risk factors and genetic susceptibility. This will allow us to 
predict and eventually prevent the consequences of combined impact of genetic 
and environmental factors.  
Early embryogenesis, implantation and placentation are affected by maternal 
nutrition in the periconceptional period 117. In particular, micronutrients such as 
vitamins and minerals play crucial roles in the development of the embryo and 
their imbalance can give rise to severe congenital defects. For instance, folate is 
involved in DNA synthesis and cell division, and its periconceptional intake 
protects against neural tube defects, as well as OFC 116, 117. Numerous studies 
have shown that a folate-rich diet or folic acid (synthetic form of folate) 
supplementation before and during early pregnancy significantly reduces the 
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incidence of OFC in human offspring 118. Furthermore, various polymorphisms 
of folate metabolic enzymes have been found to increase the risk for OFC. For 
instance, several single nucleotide polymorphisms of methylenetetrahydrofolate 
reductase (MTHFR), a key enzyme in folate metabolism, have been shown to 
reduce the activity of the enzyme. Combined with deficient maternal folate 
intake, this can lead to increased risk of OFC in the offspring 119-124. Interestingly, 
a recent study shows that folic acid can reduce primary palate clefting in 
Xenopus induced by impaired vitamin A metabolism 125. Another essential 
micronutrient, lipid-soluble vitamin A, is of a particular importance during 
embryogenesis. It  cannot be synthesized by the human body either during 
embryogenesis or in adulthood. Therefore, maternal intake of vitamin A is the 
only source for the embryo. Vitamin A is available in meat in its precursor form  
retinyl palmitate and in yellow to red-pigmented plants in the form of 
carotenoids. Once ingested, both precursors will  be eventually converted to 
either retinoic acid or retinal, two physiologically active derivatives of vitamin A 
126. The most important derivative of vitamin A during embryogenesis is  
retinoic acid (RA) 126. Several polymorphisms of RA metabolic enzymes have 
been found to contribute to congenital neural tube, heart and gastrointestinal 
defects in humans 126. Interestingly, both deficiency and excess of RA give rise to 
severe craniofacial malformations, including OFC. The inactivation of RA 
signalling through deletion of its receptors RARα and RARγ in cranial neural 
crest cells results in agenesis of the midface including the secondary palate 127, 
128. In addition, high doses of RA  lead to severe malformations in all of the 
craniofacial region including cleft of the secondary palate 129, 130. Exactly how RA 
is involved in embryogenesis, in particular, its role in palatogenesis and the 
pathogenesis of OFC is unravelled in the following chapter.  
Although genes absolutely play a role in palate morphogenesis, gene-
environment interaction too is crucial and cannot be neglected. Therefore, this 
thesis is mainly focused on RA, an environmental risk factor for OFC 
pathogenesis. The studies within this project has been performed with oral 
keratinocytes obtained from OFC patients and control individuals. Our main 
goal was to study RA effects on oral keratinocytes and find indications on 
possible RA-related molecular and cellular mechanisms in OFC. In the next 
section, a short description of the individual studies from this thesis is 
presented. 
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Objectives and outline of the thesis 
Substantial evidence from the last three decades suggests a relation between RA 
and OFC in humans, as well as in animal models 126, 131, 132. Studies in mice 
suggest a crosstalk between RA and various signalling molecules, although the 
exact mechanism of RA contribution to OFC is still not well-understood. Proper 
functioning of embryonic palatal epithelium is crucial for palatogenesis. 
Therefore, we used oral keratinocytes to study putative RA effects and epithelial 
involvement in the pathogenesis of OFC.  
In Chapter 2, we summarize the current literature and discuss RA-related 
mechanisms in the development of three ectoderm-derived epithelial tissues: 
the skin, the limbs and the secondary palate. The development of these 
structures is regulated by common and distinct signalling pathways, and 
disruption of certain pathways leads to malformations in all these three 
structures. In Chapter 3, we study the effect of RA on proliferation and gene 
expression in palatal keratinocytes derived from OFC patients and control 
subjects. In Chapter 4, we study the effect of RA in oral keratinocytes at a 
genome-wide level and search for RA-mediated deregulation of OFC genes. In 
Chapter 5, we analyze gene expression in palatal keratinocytes from OFC 
patients and control subjects. We identify and  confirm deregulated adhesion 
program in OFC cells. In Chapter 6, General Discussion, we discuss our main 
findings and their implications. 
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Abstract  
Retinoic acid (RA), the active derivative of vitamin A, is one of the major 
regulators of embryonic development, including the development of the 
epidermis, the limbs and the secondary palate. In the embryo, RA levels are 
tightly regulated by the activity of RA synthesizing and degrading enzymes. 
Aberrant RA levels due to genetic variations in the RA metabolism pathways 
contribute to congenital malformations in these structures. In vitro and in vivo 
studies provide considerable evidence on the effects of RA and its possible role 
in the development of the epidermis, the limbs and the secondary palate. In 
conjunction with other regulatory factors, RA seems to stimulate the 
development of the epidermis by inducing proliferation and differentiation of 
ectodermal cells into epidermal cells. In the limbs, the exact timing of RA 
location and level is crucial to initiate limb bud formation and to allow 
chondrogenesis and subsequent osteogenesis. In the secondary palate, the 
correct RA concentration is a key factor for cell proliferation, differentiation and 
apoptosis during palatal shelf outgrowth, elevation, fusion and finally to allow 
bone formation in the hard palate. These findings are highly relevant to 
understanding the mechanism of RA signalling in development and in the 
aetiology of specific congenital diseases. 
 
  
4 
 
Vitamin A and its derivatives 
Vitamin A is an essential micronutrient for embryonic development and growth 
in all vertebrate species 1-3. Either deficiency or excess of vitamin A outside its 
narrow optimal range is related to congenital malformations 4, 5. Vitamin A, 
more precisely, its active derivative retinoic acid (RA), is crucial for embryonic 
development from the very early stages on, since it regulates processes such as 
the establishment of the anterior-posterior and dorsal-ventral axes of the 
embryo through gradient formation 6-10. At the later stages of the 
embryogenesis, RA is involved, among others, in the development of the 
epidermis, the limbs, and the secondary palate 11. Thus, RA is indispensable for 
embryonic development, and aberrant RA metabolism and signalling are 
involved in the aetiology of many congenital diseases.  
 
Figure 1*. Retinoic acid metabolism and signaling.  
After entering the cell, maternal retinol binds to cellular retinol-binding proteins (CRBP). Retinol is then 
oxidized to retinaldehyde by either alcohol dehydrogenases (ADHs) or retinol dehydrogenases (RDHs), 
and retinaldehyde is subsequently oxidized to RA by retinaldehyde dehydrogenases 1, 2 and 3 (RALDH1, 
2, 3). Cellular RA-binding proteins (CRABP) facilitate the transport of RA to the nucleus. In the nucleus, 
RA acts as a ligand for RAR/RXR that can bind to retinoic acid response elements (RARE) in the 
regulatory regions of RA target genes. By activating the RAR/RXR-RARE complex, RA regulates the 
transcription of its target genes. RA is degraded by cytochrome P450 family 26 (CYP26A, B, C). 
*Adapted from 12.  
36 | Chapter 2
519334-L-bw-mammadova
Processed on: 7-5-2018 PDF page: 37
3 
 
Abstract  
Retinoic acid (RA), the active derivative of vitamin A, is one of the major 
regulators of embryonic development, including the development of the 
epidermis, the limbs and the secondary palate. In the embryo, RA levels are 
tightly regulated by the activity of RA synthesizing and degrading enzymes. 
Aberrant RA levels due to genetic variations in the RA metabolism pathways 
contribute to congenital malformations in these structures. In vitro and in vivo 
studies provide considerable evidence on the effects of RA and its possible role 
in the development of the epidermis, the limbs and the secondary palate. In 
conjunction with other regulatory factors, RA seems to stimulate the 
development of the epidermis by inducing proliferation and differentiation of 
ectodermal cells into epidermal cells. In the limbs, the exact timing of RA 
location and level is crucial to initiate limb bud formation and to allow 
chondrogenesis and subsequent osteogenesis. In the secondary palate, the 
correct RA concentration is a key factor for cell proliferation, differentiation and 
apoptosis during palatal shelf outgrowth, elevation, fusion and finally to allow 
bone formation in the hard palate. These findings are highly relevant to 
understanding the mechanism of RA signalling in development and in the 
aetiology of specific congenital diseases. 
 
  
4 
 
Vitamin A and its derivatives 
Vitamin A is an essential micronutrient for embryonic development and growth 
in all vertebrate species 1-3. Either deficiency or excess of vitamin A outside its 
narrow optimal range is related to congenital malformations 4, 5. Vitamin A, 
more precisely, its active derivative retinoic acid (RA), is crucial for embryonic 
development from the very early stages on, since it regulates processes such as 
the establishment of the anterior-posterior and dorsal-ventral axes of the 
embryo through gradient formation 6-10. At the later stages of the 
embryogenesis, RA is involved, among others, in the development of the 
epidermis, the limbs, and the secondary palate 11. Thus, RA is indispensable for 
embryonic development, and aberrant RA metabolism and signalling are 
involved in the aetiology of many congenital diseases.  
 
Figure 1*. Retinoic acid metabolism and signaling.  
After entering the cell, maternal retinol binds to cellular retinol-binding proteins (CRBP). Retinol is then 
oxidized to retinaldehyde by either alcohol dehydrogenases (ADHs) or retinol dehydrogenases (RDHs), 
and retinaldehyde is subsequently oxidized to RA by retinaldehyde dehydrogenases 1, 2 and 3 (RALDH1, 
2, 3). Cellular RA-binding proteins (CRABP) facilitate the transport of RA to the nucleus. In the nucleus, 
RA acts as a ligand for RAR/RXR that can bind to retinoic acid response elements (RARE) in the 
regulatory regions of RA target genes. By activating the RAR/RXR-RARE complex, RA regulates the 
transcription of its target genes. RA is degraded by cytochrome P450 family 26 (CYP26A, B, C). 
*Adapted from 12.  
2
 Retinoic acid signalling in embryonic development | 37
519334-L-bw-mammadova
Processed on: 7-5-2018 PDF page: 38
5 
 
The term “vitamin A” designates a family of related compounds possessing the 
biological activity of retinol 13. Natural and synthetic derivatives of retinol in the 
form of aldehydes or carboxylic acids are collectively called “retinoids”, and are 
involved in a wide scale of biological processes. The carboxylic acid isomer all-
trans-retinoic acid (RA) is a natural derivative of retinol and is one of the key 
regulators of gene expression during embryonic development 14, 15. RA is an 
important regulator of gene expression during embryogenesis, and mutations in 
the genes involved in RA metabolism and/or signalling cause congenital defects 
16, 17. The regulation of development of the epidermis, the limbs and the 
secondary palate includes many signalling molecules and/or pathways within 
the epithelium as well as interactions of these signals between the epithelium 
and the mesenchyme. The purpose of this review is to discuss the present 
knowledge on the role of RA in the development of these three structures. We 
will first present a short overview of RA metabolism and signalling. 
Subsequently, we will discuss its role in the development of the epidermis, the 
limbs and the secondary palate. 
 
Retinoic acid metabolism during embryonic development  
Vitamin A can be synthesized by the human body neither during embryonic 
development, nor in adulthood 13. Maternal nutritional intake is therefore the 
only source of vitamin A during embryonic development. Two precursor forms 
of vitamin A are available in the human diet: retinyl palmitate (i.e. the esterified 
form of retinol) present in meat and carotenoids (β-carotene, α-carotene, and β-
cryptoxantin) present in plants. Both dietary precursors of vitamin A are 
eventually converted into either retinoic acid (RA) or retinal, the functionally 
active derivatives of vitamin A, or are stored in the form of biologically inactive 
retinyl esters in the liver and to a lesser degree in adipose tissue 18. The complex 
spatiotemporal regulatory functions of RA requires precise control of its 
distribution and concentration, which is achieved by RA synthesizing and 
degrading enzymes (Figure 1).  
The conversion of retinol into its active derivatives is mediated by a set of 
enzymes that are classified into three groups; the cytosolic alcohol 
dehydrogenases (ADHs) of the medium-chain dehydrogenase/reductase (MDR) 
superfamily, the microsomal retinol dehydrogenases (RDHs) of the short-chain 
6 
 
dehydrogenase/reductase (SDR) superfamily and the retinaldehyde 
dehydrogenases (RALDHs) 14, 19. RA is synthesized from retinol in two steps. 
Firstly, all-trans retinol is oxidized to all-trans retinal, which is subsequently 
oxidized to all-trans retinoic acid. The rate-limiting first step is mediated by the 
ADHs and the RDHs 13. ADH4 is the most active subtype of ADHs and the first 
one expressed in the craniofacial region, trunk and forelimb bud during early 
embryogenesis 20. RDH10 seems to be the most crucial member of the SDR 
superfamily for embryonic development, since loss of its function disrupts RA 
biosynthesis and signalling in the craniofacial and the trunk regions leading to 
orofacial, limb, and organ abnormalities and ultimately to death of the embryo 
21. The second step in RA biosynthesis is mediated by the RALDH subtypes 1, 2 
and 3 in different organs and tissues  22, 23. RALDH1 is required for eye 
development and is also involved in the maintenance of adult vision 24, while 
RALDH3 is expressed in the embryonic craniofacial ectoderm. It is specifically 
present in the developing eye and nasal region 25, and together with RALDH2, it 
is responsible for RA synthesis in the craniofacial structures 26, 27. RALDH2 is the 
most essential RA synthesizing enzyme in the early mammalian embryo 28. It is 
responsible for RA synthesis in most embryonic tissues including the maxillary 
process, the forelimb buds, and the dorsal spinal cord 29. RALDH1 and RALDH3 
function later in embryonic development in specific organs such as the eye, the 
olfactory pit and the kidney 30. Once synthesized, RA is bound to cellular 
retinoic acid binding proteins (CRABP) I or II and is transported to the nucleus 
where it binds to nuclear receptors (RAR/RXR) and activates the expression of 
its target genes 31. RA signal transduction will be discussed further in the next 
section. 
RA is degraded by enzymes of the cytochrome P450-26 subfamily (CYP26A1, 
CYP26B1, and CYP26C1). All three isotypes of CYP26 show spatiotemporal 
activity throughout embryonic development and hereby control endogenous RA 
concentrations. Cyp26A1 is the first RA degrading enzyme functioning during 
embryonic development followed by Cyp26C1 and Cyp26B1. While Cyp26A1 is 
expressed in the tail bud neuroepithelium and the cervical neural crest-derived 
mesenchyme, CYP26B1 is expressed in the developing limb bud and in the 
maxillary and mandibular processes. Cyp26C1 is only transiently expressed in 
the hindbrain 32-35.  
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most essential RA synthesizing enzyme in the early mammalian embryo 28. It is 
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its target genes 31. RA signal transduction will be discussed further in the next 
section. 
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Thus, RA is generated from maternal retinol in several steps and is active from 
the earliest stages of the embryogenesis. Its spatiotemporal distribution is 
achieved and is regulated by RA synthesizing and degrading enzymes. In the 
next section we will discuss mutations of the metabolizing enzymes and their 
adverse effects on embryonic development. 
 
Retinoic acid signalling during embryonic development 
Physiologically, RA functions within a narrow concentration window and both 
too high or too low levels of RA are detrimental for early embryogenesis and 
morphogenesis 4, 5. RA is synthesized for the first time in the primitive streak 
stage of mouse embryos undergoing gastrulation at embryonic day 7.5 (E7.5) 20. 
Raldh2, is the key retinaldehyde dehydrogenase for early RA synthesis in the 
embryo 36, 37. Initially it is expressed only in the trunk, but it is also found in the 
posterior hindbrain and the eye by E8.5 29. Interestingly, RA synthesis at this 
stage coincides with the initiation of neural crest cell (NCC) migration. These 
cells will give rise to a wide variety of derivatives, including craniofacial 
structures like the palate and the teeth 38-40. The ablation of Raldh2 in mice 
results in embryonic lethality with severe abnormalities in early morphogenesis 
23. Disruption of early embryonic RA biosynthesis also causes craniofacial and 
limb malformations. For instance, knockout of Rdh10 causes orofacial clefting 
and limb abnormalities 21, while knockout of the dehydrogenase/reductase 
superfamily member 3 (Dhrs3) leads to late embryonic lethality and cleft palate 
41. The expression of Rdh10, Raldh1, Raldh2, and Raldh3 are down-regulated in 
Dhrs3-/- mice, while the expression of Cyp26a1 is up-regulated. The RA-
degrading enzymes Cyp26a1, Cyp26c1 and Cyp26b1 are expressed in the mouse 
embryo starting from early gastrulation (E7) and the onset of organogenesis 
(E8) 33, 42. Cyp261a-deficient mouse embryos die before birth and display central 
nervous system (CNS) and hindlimb anomalies 43. Cyp26b1 knockout causes 
severe limb malformations and facial abnormalities such as a shortened 
mandible and reduced ossification of the maxilla and premaxilla 22. Cyp26c1 
knockout alone does not affect embryonic development due to functional 
redundancy between CYP26a1 and CYP26c1 42. However, combined knockout of 
Cyp26a1 and Cyp26c1 causes severe CNS abnormalities and impaired production 
of cranial NCC cells due to elevated RA concentrations 42. A more detailed 
8 
 
overview of the mutations of Cyp26 enzymes and their consequences for 
embryonic development has been discussed elsewhere 1. These studies indicate 
that correct expression of RA synthesizing and degrading enzymes at the right 
location and level is critical for normal embryonic development. Mutations in 
these enzymes disturb the normal RA levels and consequently impair 
embryogenesis.  
The effects of RA are mediated by the RA receptors (RAR) and the retinoid X 
receptors (RXR), which are located in the nucleus. Both RARs and RXRs consist 
of three different isotypes – α, β, γ and multiple isoforms – generating a large 
group of possible heterodimers. In addition, RXRs can heterodimerize with 
several non-RA associated nuclear receptors and thereby mediate other 
signalling pathways 31. This explains how retinoids can regulate a broad diversity 
of biological processes. Yet, most of the RA-dependent processes are mediated 
by RAR/RXR heterodimerization 5.  
Similar to other nuclear receptors, the presence of a ligand is required for the 
activation of the retinoid receptors. RAR can be activated by both all-trans RA 
and 9-cis RA, whereas RXR can only be activated by 9-cis RA and certain fatty 
acids (reviewed in 44). RARs and RXRs bind to retinoic acid response elements 
(RARE), short DNA sequences in the regulatory regions of the target genes 45. In 
the absence of RA, RAR exhibits repressive activity as it interacts with 
corepressors and recruits repressor complexes that deacetylate histones 46. In 
the presence of RA, the RAR/RXR-RARE complex recruits a coactivator complex 
that acetylates histones, thus allowing transcription. In fact, the RAR/RXR 
heterodimer is mainly activated by binding of RA tot RAR, but not by single 
binding of RXR ligands to RXR 47. Thus, RAR is the major receptor to activate 
the transcription of target genes. Presumably, this mechanism is to avoid cross-
activation of other signalling pathways where RXR acts as a partner monomer. 
The simultaneous knockout of two or more RAR isotypes causes congenital 
abnormalities in almost all embryonic structures derived from mesenchymal 
neural crest cells (NCC) (reviewed in 11; 48). This suggests that RARs are 
indispensable for RA signalling during embryogenesis and organogenesis.  In 
contrast, double homozygous knockouts of RXRγ/RXRβ alone, as well as those 
combined with a heterozygous RXRα knockout mutation are viable, essentially 
normal, and display no obvious congenital abnormalities, besides a marked 
40 | Chapter 2
519334-L-bw-mammadova
Processed on: 7-5-2018 PDF page: 41
7 
 
Thus, RA is generated from maternal retinol in several steps and is active from 
the earliest stages of the embryogenesis. Its spatiotemporal distribution is 
achieved and is regulated by RA synthesizing and degrading enzymes. In the 
next section we will discuss mutations of the metabolizing enzymes and their 
adverse effects on embryonic development. 
 
Retinoic acid signalling during embryonic development 
Physiologically, RA functions within a narrow concentration window and both 
too high or too low levels of RA are detrimental for early embryogenesis and 
morphogenesis 4, 5. RA is synthesized for the first time in the primitive streak 
stage of mouse embryos undergoing gastrulation at embryonic day 7.5 (E7.5) 20. 
Raldh2, is the key retinaldehyde dehydrogenase for early RA synthesis in the 
embryo 36, 37. Initially it is expressed only in the trunk, but it is also found in the 
posterior hindbrain and the eye by E8.5 29. Interestingly, RA synthesis at this 
stage coincides with the initiation of neural crest cell (NCC) migration. These 
cells will give rise to a wide variety of derivatives, including craniofacial 
structures like the palate and the teeth 38-40. The ablation of Raldh2 in mice 
results in embryonic lethality with severe abnormalities in early morphogenesis 
23. Disruption of early embryonic RA biosynthesis also causes craniofacial and 
limb malformations. For instance, knockout of Rdh10 causes orofacial clefting 
and limb abnormalities 21, while knockout of the dehydrogenase/reductase 
superfamily member 3 (Dhrs3) leads to late embryonic lethality and cleft palate 
41. The expression of Rdh10, Raldh1, Raldh2, and Raldh3 are down-regulated in 
Dhrs3-/- mice, while the expression of Cyp26a1 is up-regulated. The RA-
degrading enzymes Cyp26a1, Cyp26c1 and Cyp26b1 are expressed in the mouse 
embryo starting from early gastrulation (E7) and the onset of organogenesis 
(E8) 33, 42. Cyp261a-deficient mouse embryos die before birth and display central 
nervous system (CNS) and hindlimb anomalies 43. Cyp26b1 knockout causes 
severe limb malformations and facial abnormalities such as a shortened 
mandible and reduced ossification of the maxilla and premaxilla 22. Cyp26c1 
knockout alone does not affect embryonic development due to functional 
redundancy between CYP26a1 and CYP26c1 42. However, combined knockout of 
Cyp26a1 and Cyp26c1 causes severe CNS abnormalities and impaired production 
of cranial NCC cells due to elevated RA concentrations 42. A more detailed 
8 
 
overview of the mutations of Cyp26 enzymes and their consequences for 
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receptors (RXR), which are located in the nucleus. Both RARs and RXRs consist 
of three different isotypes – α, β, γ and multiple isoforms – generating a large 
group of possible heterodimers. In addition, RXRs can heterodimerize with 
several non-RA associated nuclear receptors and thereby mediate other 
signalling pathways 31. This explains how retinoids can regulate a broad diversity 
of biological processes. Yet, most of the RA-dependent processes are mediated 
by RAR/RXR heterodimerization 5.  
Similar to other nuclear receptors, the presence of a ligand is required for the 
activation of the retinoid receptors. RAR can be activated by both all-trans RA 
and 9-cis RA, whereas RXR can only be activated by 9-cis RA and certain fatty 
acids (reviewed in 44). RARs and RXRs bind to retinoic acid response elements 
(RARE), short DNA sequences in the regulatory regions of the target genes 45. In 
the absence of RA, RAR exhibits repressive activity as it interacts with 
corepressors and recruits repressor complexes that deacetylate histones 46. In 
the presence of RA, the RAR/RXR-RARE complex recruits a coactivator complex 
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The simultaneous knockout of two or more RAR isotypes causes congenital 
abnormalities in almost all embryonic structures derived from mesenchymal 
neural crest cells (NCC) (reviewed in 11; 48). This suggests that RARs are 
indispensable for RA signalling during embryogenesis and organogenesis.  In 
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growth deficiency 49. This suggests that the RXR isotypes can replace each other 
and that RXRβ and RXRγ are dispensable when RXRα is present. Interestingly, 
compound RAR/RXRα-null mutants do exhibit congenital defects overlapping 
with the defects caused by compound RAR null mutants. For instance, either 
compound RXRα-/-/RARγ-/- mutations or RARα-/-/RARγ-/- mutations cause 
multiple craniofacial defects 11, suggesting that the RXRα, RARα and RARγ are 
the most important receptor isotypes during craniofacial development. 
Accordingly, mutations in the genes coding for these receptors can lead to 
diverse abnormalities (extensively reviewed in 50). Next, we will discuss RA 
function in the development of the epidermis, the limb and secondary palate 
specifically. 
 
RA in the development of the epidermis  
Mammalian epidermis develops from a single-layer embryonic surface ectoderm 
in several stages, which may also include the development of related derivatives 
such as hairs and teeth 51. RA  regulates different stages of epidermal 
development including epidermal commitment, stratification and terminal 
differentiation 52, 53. The multipotent cells of the surface ectoderm firstly 
undergo growth arrest followed by an epidermal  differentiation program, which 
is characterized by the onset of  Keratin 5 (K5) and Keratin 14 (K14) expression 
at E9.5 in the mouse embryo 52. In vitro studies on human embryonic stem cells 
(hESCs) show that the expression of K18, which is the predominant cytokeratin 
of the embryonic surface epithelium, is up-regulated in embryonic bodies (EBs) 
cultured with RA. EBs treated with RA generate significant populations of K14 
expressing cells when BMP is present 53. This study suggests that RA signalling 
stimulates ectodermal cells to gain epidermal fate with the condition that BMP 
signalling prevents early neural differentiation. After the cells have committed 
to the epidermal fate, they undergo stratification 52. By E15.5 the epidermal cells 
terminally differentiate and switch from the expression of K5/K14  to K1/K10, the 
first markers of the differentiating keratinocytes, in the first suprabasal cells 52. 
RA induces the proliferation of human epidermal keratinocytes and inhibits 
their differentiation in vitro 54. Moreover, both systemic and topical application 
of RA in vivo also induces proliferation of basal keratinocytes which increases 
the number of suprabasal layers and causes epithelial thickening, also called 
10 
 
epidermal hyperplasia 55. Collectively, these studies suggest that in conjunction 
with other regulatory factors, RA has a direct stimulatory effect on the 
development of epidermis through inducing proliferation and differentiation of 
the embryonic surface ectodermal cells.  
Human epidermis expresses RARα, RARγ, RXRα, RXRβ, with RARγ/RXRα being 
the most predominant receptor dimer 55. Mutations in RARα result in severe 
epidermal underdevelopment, manifested as a thin, smooth and fragile skin 
with no wrinkles or hairs 17. Mutations of RXRα significantly reduces the 
proliferation of basal keratinocytes in vivo 56. The RARγ/RXRα complex mediates 
the retinoic-induced hyperproliferation through up-regulation of heparin-
binding EGF-like growth factor (HB-EGF) 57, 58. HB-EGF expression in the 
suprabasal layers of the epidermis stimulates proliferation in the basal layer 59. 
Although RXRα is the main RXR isotype in epidermal keratinocytes, it can be 
partially replaced by RXRβ 60. This is the case in the regulation of RA target 
genes such as HB-EGF or cellular RA binding protein-II (CRABPII) 57. Hence, RA 
functions in the epidermis are transduced mainly by the RARα/RXRα 
heterodimer in the basal layer and the RARγ/RXRα heterodimer in the 
suprabasal layers 61.  
The endogenous RA concentrations in epidermal cells are regulated by both RA 
synthesizing and RA degrading enzymes. Interestingly, RA reduces the 
expression of retinol dehydrogenase 16 (RDH16) and retinaldehyde 
dehydrogenase 2 (RALDH2) in vitro 62. CRABPII and cellular retinol binding 
protein (CRBP) I and II are directly up-regulated by RA through the RAREs in 
their promoter regions 55. Also the expression of CYP26A1 and CYP26B1 in 
epidermal keratinocytes is strongly induced by RA 32, 62. These studies suggest 
that  RA regulates its own concentration by adjusting the expression levels of its 
metabolising enzymes. 
Along with RA, several other signalling molecules including the transcription 
factor p63, the activator proteins 1 (AP-1) and 2 (AP-2), and signalling pathways 
such as Notch,  Wnt and Fgf are involved in the regulation of epidermal 
development and may interact with RA signalling 51, 63. From these regulatory 
factors, p63 is a key regulator of epidermal development and differentiation 64. 
Mice lacking p63 fail to develop an epidermis and its appendages including 
teeth 65-67. Ablation of p63 also causes defective limb and craniofacial 
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development which will be discussed in the next sections. Moreover, syndromes 
caused by p63 mutations exhibit epidermal manifestations such as ectodermal 
dysplasias 64, 68. Interestingly, the epidermal manifestations of mutated RARα are 
similar to those of p63 ablation 69. Therefore, an interaction between these two 
pathways has been hypothesized. RA inhibits terminal differentiation of human 
adult keratinocytes by preventing down-regulation of the ΔN isoform of p63 
(ΔNp63α) 70. However, RA has a different effect on embryonic stem cells 
through the interaction with p63. RA-treated human embryonic stem cells 
express p63 and readily differentiate into keratinocytes while BMP signalling 
represses neural differentiation  53. This contradictory effect of RA on the 
differentiation of adult keratinocytes and embryonic stem cells might be due to 
distinct cell types and distinct regulatory mechanisms involved. The TAp63 
isoform of p63 induces the expression of retinal short-chain 
dehydrogenase/reductase (retSDR1) in cancer cells both in vitro and in vivo 71, 
suggesting that p63 regulates RA biosynthesis. These studies indicate that there 
might be a functional  interaction between RA signalling and p63, however the 
exact mechanism requires further investigation. The current evidence on the 
direct cellular effects of RA and molecular interactions with other signalling 
molecules and pathways in the development of the epidermis are summarized 
in Table 1.  
Although the effects of RA on the development of epidermal appendages is 
outside the scope of this review, it is worth mentioning that RA inhibits  hair 
development in mouse embryos 60, 72. It is also known that the RA synthesizing 
enzyme Raldh2 is absent in developing rat tooth germs 73, in contrast to the RA 
degrading enzyme Cyp26c1 which is highly expressed 34. This might indicate that 
RA is not present in tooth development. On the other hand, Cyp26b1-/- mouse 
embryos develop no lower incisor buds 22 implying that RA signalling might be 
involved in the development of the lower incisor teeth. From the major 
signalling pathways regulating tooth morphogenesis (reviewed in 74-77), Notch 
proteins are the only known signalling molecules to be induced by RA in the 
dental mesenchyme 78. Thus, extensive knowledge on the role of RA in the 
development of teeth and other epidermal appendages is lacking and therefore 
requires more research. 
  
12 
 
Table 1. RA effects on the development of the epidermis, the limbs and the secondary palate 
 Epidermis Limbs Secondary palate 
Ce
llu
la
r e
ff
ec
ts
  ↑ Proliferation of epidermal 
keratinocytes 54-59. 
 ↑ Differentiation of embryonic 
surface ectodermal cells  into 
epidermal keratinocytes 17, 52-54, 
61. 
 
 ↓ Proliferation and 
differentiation of pre-
chondrogenic cells into 
chondroblasts,  
 ↑ apoptosis the central limb bud 
cells  79-84. 
 ↓ Differentiation of osteoblasts 
and bone mineralisation 85. 
↓ Proliferation of human palatal 
keratinocytes 86. 
 ↑ Apoptosis in murine 
embryonic palatal mesenchyme 87-
90. 
 ↓ Adhesion of the palatal shelves 
87. 
 ↓ Chondrogenesis and bone 
formation in the developing  hard 
palate  91-93. 
 
M
ol
ec
ul
ar
 in
te
ra
ct
io
ns
  RA maintains ΔNp63α 
expression in epidermal 
keratinocytes and hereby 
inhibits their terminal  
differentiation 70.  
 TAp63 induces the expression 
of retinal short-chain 
dehydrogenase/reductase 
(retSDR1) in cancer cells both in 
vitro and in vivo 71. 
 RA up-regulates the expression of 
Meis1 and Meis2 genes 94-96. 
 RA and Fgfs counteract each 
other 94-96. 
 RA up-regulates the expression 
of Shh in the limb bud 97. 
 Shh is required for proximal 
restriction of RA 98.                                                                                      
 RA up-regulates the expression 
of Hoxb-8 99, 100. 
 RA inhibits the expression of 
Sox9 and Col2a1 79, 81-83, 101. 
 RA down-regulates the 
expression of p63 in limb bud 
cells 82. 
 
RA and the canonical Wnt 
signalling antagonize each other 
during lip and palate development 
102, 103.  
 RA down-regulates the 
transcription of histone 
methyltransferase Whsc1 104.                                                  
 RA down-regulates the
expression of p63 and its target 
genes GJB6 and DLX5 in human 
palatal keratinocytes 86. 
Abbreviations and symbols: ↑, induction; ↓, reduction; RA, retinoic acid; ΔNp63α, ΔN isoform of p63;  
TAp63, TA isoform of p63; Fgf, Fibroblast growth factor; Shh, Sonic hedgehog. 
 
 
Various (congenital) skin disorders such as epidermolysis bullosa, epidermolytic 
hyperkeratosis and ichtyosis, as well as psoriasis, and precancerous skin lesions 
respond positively to retinoid treatment. This suggests that insufficient RA 
concentrations in the epidermis might contribute to the aetiology of these skin 
disorders. Therefore, RA might be one of the key factors regulating epidermal 
commitment, stratification and terminal differentiation. Aberrant RA signalling 
due to abnormal RA concentration or loss of function through mutated retinoid 
receptors disturbs normal epidermal development. Furthermore, RA signalling 
and p63 seem to interact in the epidermis. Thus, further research will 
undoubtedly shed light on how RA functions and interactions during epidermal 
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of Hoxb-8 99, 100. 
 RA inhibits the expression of 
Sox9 and Col2a1 79, 81-83, 101. 
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RA and the canonical Wnt 
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102, 103.  
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methyltransferase Whsc1 104.                                                  
 RA down-regulates the
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Abbreviations and symbols: ↑, induction; ↓, reduction; RA, retinoic acid; ΔNp63α, ΔN isoform of p63;  
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Various (congenital) skin disorders such as epidermolysis bullosa, epidermolytic 
hyperkeratosis and ichtyosis, as well as psoriasis, and precancerous skin lesions 
respond positively to retinoid treatment. This suggests that insufficient RA 
concentrations in the epidermis might contribute to the aetiology of these skin 
disorders. Therefore, RA might be one of the key factors regulating epidermal 
commitment, stratification and terminal differentiation. Aberrant RA signalling 
due to abnormal RA concentration or loss of function through mutated retinoid 
receptors disturbs normal epidermal development. Furthermore, RA signalling 
and p63 seem to interact in the epidermis. Thus, further research will 
undoubtedly shed light on how RA functions and interactions during epidermal 
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development and will create new therapies for the treatment of epidermal 
diseases.  
 
RA in the development of the limbs  
Limbs develop from small buds protruding from the lateral sides of the body 
along the cranial-caudal axis. Mouse genetic and chick embryo manipulation 
experiments have identified several molecular interactions in two signalling 
centres – the apical ectodermal ridge (AER) and the zone of polarizing activity 
(ZPA). The AER is localized at the most distal epithelial tip of the limb bud, and 
the ZPA is localized in the posterior mesenchyme below the AER. Signals from 
these centres coordinate limb growth and patterning in proximal-distal (PD) 
and anterior-posterior (AP) axes 105-107. 
RA receptor mutations in mouse embryos cause abnormal limbs indicating RA 
involvement in limb development 16. Prior to limb bud initiation, RA 
biosynthesis starts from the trunk mesoderm proximal to the presumptive limb 
bud 23 where it represses the expression of Fgf8 to allow limb initiation 108, 109. It 
continues to function during the PD (from shoulder to digits) and AP (from 
thumb to little finger) patterning of the limb. The role of RA in PD limb 
patterning is explained by the “two-signal” model, meaning that the 
antagonistic effects of Fgfs and RA determine the PD patterning of the limb. RA 
induces proximal patterning of the limb by up-regulating and maintaining the 
Meis1 and Meis2 genes, the proximal determinants of the limb bud. Fgfs (Fgf4, 
Fgf8, Fgf9 and Fgf17) expressed at the AER, the signalling centre for PD 
patterning, induce distal patterning by down-regulating the expression of Meis1 
and Meis2 through RA-Fgf antagonism 94-96. Fgfs counteract RA signalling by 
reducing the expression of genes encoding for its receptor RARβ and its 
synthesizing enzyme Raldh2 95.  However, more recent studies have been 
challenging the “two-signal” hypothesis and claim that RA is dispensable for 
limb patterning. This would mean that, RA-Fgf antagonism is only necessary for 
limb bud initiation, but not for the PD patterning 109-112. Hence, more research in 
this field is required to solve this controversy.  
AP patterning and digit specification is mediated by Sonic hedgehog (Shh) from 
the ZPA, which is the centre for the AP patterning of the limb 113.  Mutations in 
14 
 
functional ZPA cells which then causes mirror-image digit duplication 99, 100. 
This occurs through expression of Hoxb-8, which is the primary response gene 
for RA 116. Also the expression of Shh is up-regulated by RA 97. Accordingly, 
blocking RA signalling results in the loss of Hoxb-8 expression accompanied by 
simultaneous loss of polarizing activity 116. In vitro studies with forelimb buds of 
the Shh knockout mice revealed that the forelimb buds are proximalized due to 
increased RA activity 98. In other words, RA activity increases in the absence of 
Shh, which causes the limb bud to gain a proximal character. This also shows 
that Shh signalling is required for the proximal restriction of RA signalling 
during limb bud outgrowth.  
Like most parts of the mammalian skeleton, limbs develop from a cartilage 
template which is subsequently replaced by mineralized bone. This process is 
called endochondral ossification 117. Endochondral ossification and its regulation 
are discussed in detail somewhere else 118, 119. Both in vivo and in vitro studies 
indicate that correct levels of RA are important for normal chondrogenesis in 
the developing limb 117, 119, 120. Numerous mouse studies indicate that either 
excess or deficiency of RA disrupts chondrogenesis through inhibition of 
proliferation and differentiation of mesenchymal precursor cells 79-84. 
Interestingly, RA-induced cartilage defects are more severe in the forearms than 
in the hands indicating that RA has position-related effects 121. At the molecular 
level RA inhibits the expression of Sox9 and Col2a1, essential markers of 
chondrogenesis 79, 81-83, 101. This maintains the prechondrogenic cell phenotype 
and inhibits chondroblast differentiation. In the later stages of bone formation, 
excessive RA seems to inhibit osteoblast differentiation and mineralisation 85. 
Therefore, correct RA levels, in conjunction with other factors, allow 
chondrogenesis and the subsequent transformation into bone. 
RA is synthesized by Raldh2 and metabolised by Cyp26 in the wing-bud of chick 
embryos. Raldh2 is abundantly present from stage 12 until stage 15 during wing-
bud initiation and until stage 16 in the leg bud, whereas Cyp26 is present in high 
concentrations from stage 15 on 122. In mouse embryos, RA is synthesized by 
Raldh2 and degraded by Cyp26b1 in the distal region of the developing limb bud 
123. Ablation of Raldh2 results in the absence of limb buds 23, while ablation of 
Cyp26b1 results in severe limb malformations including limb truncation. Raldh2 
knockout mice exhibit reduced Fgf4 expression in the AER and strongly reduced 
Shh expression in the ZPA 124. AER and ZPA are interlinked by an epithelial-
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simultaneous loss of polarizing activity 116. In vitro studies with forelimb buds of 
the Shh knockout mice revealed that the forelimb buds are proximalized due to 
increased RA activity 98. In other words, RA activity increases in the absence of 
Shh, which causes the limb bud to gain a proximal character. This also shows 
that Shh signalling is required for the proximal restriction of RA signalling 
during limb bud outgrowth.  
Like most parts of the mammalian skeleton, limbs develop from a cartilage 
template which is subsequently replaced by mineralized bone. This process is 
called endochondral ossification 117. Endochondral ossification and its regulation 
are discussed in detail somewhere else 118, 119. Both in vivo and in vitro studies 
indicate that correct levels of RA are important for normal chondrogenesis in 
the developing limb 117, 119, 120. Numerous mouse studies indicate that either 
excess or deficiency of RA disrupts chondrogenesis through inhibition of 
proliferation and differentiation of mesenchymal precursor cells 79-84. 
Interestingly, RA-induced cartilage defects are more severe in the forearms than 
in the hands indicating that RA has position-related effects 121. At the molecular 
level RA inhibits the expression of Sox9 and Col2a1, essential markers of 
chondrogenesis 79, 81-83, 101. This maintains the prechondrogenic cell phenotype 
and inhibits chondroblast differentiation. In the later stages of bone formation, 
excessive RA seems to inhibit osteoblast differentiation and mineralisation 85. 
Therefore, correct RA levels, in conjunction with other factors, allow 
chondrogenesis and the subsequent transformation into bone. 
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concentrations from stage 15 on 122. In mouse embryos, RA is synthesized by 
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123. Ablation of Raldh2 results in the absence of limb buds 23, while ablation of 
Cyp26b1 results in severe limb malformations including limb truncation. Raldh2 
knockout mice exhibit reduced Fgf4 expression in the AER and strongly reduced 
Shh expression in the ZPA 124. AER and ZPA are interlinked by an epithelial-
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mesenchymal feedback loop generating Fgf expression in AER and Shh 
expression in ZPA 125. Although the exact mechanism of RA signalling in 
mammalian limb development is not completely understood yet, studies with 
chick and mouse embryos suggest that RA is crucial for the AER – ZPA feedback 
loop which is also reinforced by reduced Fgf4 and Shh expression in RA-
deficient mice  124.  
Once the PD and AP axes have been established, RA is generated in the 
interdigital zone by Raldh2, while Cyp26b1 in the expressed within the digits 126. 
RA induces apoptosis of the interdigital tissue which leads to digit separation 110, 
127. Digit separation is impaired in either RARα or RARγ-null mutations, as well 
as in heterozygous RXRα mutations 11.  RARα-/-/RARγ-/- exhibit limb 
malformations such as syndactyly, polydactyly and ectrodactyly 16. Together, 
these studies emphasize the importance of RA signalling in limb development. 
The transcription factor p63 is another important factor in limb development 68. 
Mutations in p63 cause limb defects in humans and ablation of p63 in mouse 
results in the absence or truncation of limbs 65, 66, 82. p63 is expressed in the AER 
128, 129 and seems to maintain the proliferative activity of the AER cells 130. Since 
RA induces apoptosis of embryonic limb cells, this might occur through the 
interaction between RA signalling and p63. It has been suggested that RA down-
regulates the expression of p63 in limb bud cells 82 which might indicate an 
interaction between RA signalling and p63. More research is necessary to clarify 
the interaction between RA signalling and p63 in limb development. The 
current evidence on the direct cellular effects of RA and its molecular 
interactions with other signalling molecules in the development of the limbs are 
summarized in the Table 1. 
 
RA in the development of craniofacial structures: the 
secondary palate 
The three embryonic germ layers – ectoderm, mesoderm and endoderm – plus 
the cranial neural crest cells (NCC) contribute to the development of vertebrate 
craniofacial structures. Cranial NCC (CNCC) that give rise to the maxilla derive 
from the forebrain and midbrain region, while those that give rise to the 
mandible derive from the midbrain and hindbrain region. Among others, CNCC 
16 
 
populations also contribute to the formation of the palate and the dental 
follicles 131. The development of the craniofacial structures requires tightly 
regulated cellular processes including differentiation, proliferation and 
migration of CNCCs leading to the correct outgrowth of the facial primordia. 
Along with members of major signalling pathways such as Fgf, Tgfβ, Shh, and 
Wnt 132, RA seems to play a key regulatory role in craniofacial development. 
Both deficiency and excess of RA cause severe craniofacial deformities in mice. 
Ablation of RARα and RARγ in CNCC causes agenesis of the midface, the 
premaxilla, the secondary palate and the nose 16, 133, whereas high doses of RA 
cause severe malformations in all craniofacial structures, including the palate 134. 
In human development, palatogenesis takes place between the 6th and 12th week, 
whereas in mouse it occurs between the 12th and 16th embryonic day (E12-16). 
Secondary palate formation involves palatal shelf outgrowth, elevation, 
adhesion and fusion after disintegration of the midline epithelial seam (MES). A 
failure in any of these processes might cause clefting. Interestingly, RA is known 
to be involved in most of these processes. In vivo, RA treatment of pregnant 
mice and rats leads to cleft palate in the embryos as a consequence of reduced 
palatal shelf outgrowth and delayed shelf elevation 87, 135, 136. Accordingly, in vitro 
studies show that RA induces cell cycle arrest and apoptosis in the mouse 
embryonic palatal mesenchymal cells 89, 90. Ablation of Cyp26b1 which encodes 
the main RA-degrading enzyme in the developing mouse palate, causes a 
complete cleft due to impaired palatal shelf elevation 22, 137. High concentrations 
of RA might reduce hyaluronic acid synthesis and thereby limit shelf expansion 
and elevation 135, 138. In addition, excessive RA might impair the development of 
the mandible and tongue, which causes the tongue to hinder shelf elevation 137, 
139, 140.  
Proper adhesion of the palatal shelves is the next crucial step in palatogenesis. 
RA treatment of pregnant rats causes impaired shelf adhesion 87. Interestingly, 
RA treatment also decreases the proliferation of human palatal epithelial cells in 
vitro 86 as well as their differentiation (unpublished data).  RA also increases 
apoptosis in the midline edge epithelium 87, 88. These studies indicate that RA 
suppresses proper palatogenesis through reducing proliferation and 
differentiation of epithelial cells and inducing their apoptosis. In addition, 
similar to limb development, high concentrations of RA suppress 
chondrogenesis and bone formation in the developing  hard palate  91-93.  These 
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adhesion and fusion after disintegration of the midline epithelial seam (MES). A 
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to be involved in most of these processes. In vivo, RA treatment of pregnant 
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studies show that RA induces cell cycle arrest and apoptosis in the mouse 
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the main RA-degrading enzyme in the developing mouse palate, causes a 
complete cleft due to impaired palatal shelf elevation 22, 137. High concentrations 
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the mandible and tongue, which causes the tongue to hinder shelf elevation 137, 
139, 140.  
Proper adhesion of the palatal shelves is the next crucial step in palatogenesis. 
RA treatment of pregnant rats causes impaired shelf adhesion 87. Interestingly, 
RA treatment also decreases the proliferation of human palatal epithelial cells in 
vitro 86 as well as their differentiation (unpublished data).  RA also increases 
apoptosis in the midline edge epithelium 87, 88. These studies indicate that RA 
suppresses proper palatogenesis through reducing proliferation and 
differentiation of epithelial cells and inducing their apoptosis. In addition, 
similar to limb development, high concentrations of RA suppress 
chondrogenesis and bone formation in the developing  hard palate  91-93.  These 
2
 Retinoic acid signalling in embryonic development | 49
519334-L-bw-mammadova
Processed on: 7-5-2018 PDF page: 50
17 
 
studies indicate that proper regulation of the endogenous RA concentrations is 
a key factor in palatal shelf outgrowth, elevation and adhesion. 
Next to its direct cellular effects, RA also interacts with canonical Wnt signalling 
which plays a significant role in the development of midfacial structures 
including the upper lip, the primary and the secondary palate 141-143. 
Consequently, mutations in this pathway are strongly associated with orofacial 
clefting 143-146. Deletion of Lrp6, an important co-receptor for canonical Wnt 
signalling, results in fully penetrant cleft palate, cleft lip, and a midline cleft of 
the mandible in mice 103. Mesenchymal proliferation in the medial and lateral 
nasal processes of these Lrp6 knockout mice was reduced. Probably, insufficient 
tissue growth led to failure of lip fusion which might secondarily prevent palatal 
fusion. Interestingly, Raldh3 expression, which is normally restricted to the 
nasal and ocular epithelium where it is responsible for RA synthesis 147, had 
expanded into the fusion region in the upper lip and nasal prominences in these 
mice 103. This study suggests that Lrp6 normally restricts Raldh3 expression to 
the nasal and ocular regions and that ectopic RA signalling might cause clefting. 
RA completely inhibits canonical Wnt signalling in primary mouse embryonic 
palatal mesenchymal cells and thereby causes clefting 102. These studies indicate 
that RA and the canonical Wnt signalling antagonize each other during lip and 
palate development. Since the Shh and Fgf pathways are the major downstream 
targets of Wnt signalling during craniofacial development 148-150, these pathways 
are probably affected as well. 
Recently, it has been shown that RA down-regulates the transcription of the 
histone methyltransferase gene Whsc1, mutations of which cause Wolf-
Hirschhorn syndrome including orofacial clefting and tooth agenesis 151. Down-
regulated Whsc1 expression causes reduced mesenchymal proliferation in the 
palatal shelves and causes clefting  in mice 104. Possibly, the inhibition of 
proliferation occurs as a result of an interaction of Whsc1 with Wnt signalling 
104. Hence, RA might also play a role in the aetiology of syndromic forms of 
orofacial clefting. Orofacial clefting is one of the three most common features of 
p63-related syndromes along with skin and limb defects 68, 152. p63 is highly 
expressed in the epithelium of the palatal shelves of mouse embryos 153, 154 and 
might be a key regulator of the differentiation of the palatal epithelium prior to 
adhesion. Previously, we have shown that the expression of p63 and its target 
genes GJB6 and DLX5 is down-regulated in RA-treated human palatal 
18 
 
keratinocytes 86. This also indicates an interaction between RA signalling and 
p63 in the palatal epithelium. Taken together, these studies suggest that RA is a 
key factor in palatogenesis, either through its direct cellular effects, or through 
its interaction with other signalling molecules. Further research is necessary to 
fully elucidate the role of RA in the regulation of palatogenesis. The current 
evidence on the direct cellular effects of RA and interactions with other 
signalling molecules in the development of the palate are summarized in the 
Table 1. 
 
RA signalling-related diseases 
Several studies suggest a correlation between genetic variations and 
polymorphisms in RA metabolic enzymes and neural tube, heart and 
gastrointestinal defects in humans 155-158. A homozygous loss-of-function 
mutation in CYP26B1 causes multiple skeletal defects including long-bone 
fusions and craniosynostosis in humans 159. This is probably due to excessive 
levels of RA which might lead to the premature mineralisation of joints and 
sutures.  
Polymorphisms in RALDH2 and CYP26A1 have been linked to neural tube 
defects such as spina bifida 155, 158. These polymorphisms might impair the ability 
of the enzyme(s) to regulate endogenous RA concentrations which in turn 
might disturb neural tube closure. Another study showed that low post-birth 
serum concentrations of RBP4 and retinol is related to non-syndromic orofacial 
clefting 160. Polymorphisms in the genes encoding retinoid transport proteins 
might lead to RA deficiency and disrupt proper gene regulation. 
Studies on the endogenous RA concentrations in embryonic tissues are lacking, 
but the RA concentrations used for in vitro and in vivo studies are probably 
above the physiological concentrations. Therefore, these studies might not 
reflect the physiological functions of RA in the embryo. The estimated average 
requirement (EAR) for retinol (vitamin A) is 550 μg during pregnancy according 
to the Food and Nutrition Board of the Institute of Medicine (US) 161. The EAR is 
also not based on known RA concentrations in embryonic tissues, but on the 
concentration of retinol in the foetal liver and on the assumption that the liver 
contains at least half of the body’s retinol. Studies in newborns show no 
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correlation between serum RA and serum retinol concentrations 162, 163. Although 
numerous studies performed in vitro and in vivo provide valuable insights into 
RA functions during embryonic development, they should be interpreted 
cautiously.   
 
Conclusion 
Current evidence indicates that RA plays a crucial regulatory role in the 
development of the epidermis, the limbs and the secondary palate. This is 
through its direct cellular effects and through its interaction with other 
signalling molecules. Together with other regulatory factors, RA is required to 
initiate the development of epidermis through the induction of proliferation 
and differentiation of embryonic ectodermal cells into epidermal cells. In the 
limbs, proper regulation of RA levels is crucial to initiate limb bud formation 
and to allow chondrogenesis and the transformation of cartilage into bone. 
Moreover, RA-induced apoptosis is required for digit separation. In the palate, 
RA is a key factor in palatal shelf outgrowth, elevation and adhesion, and to 
regulate bone formation in the hard palate. Overall it appears that correct RA 
levels, with respect to location and timing, are crucial for the development of 
the epidermis, the limbs and the secondary palate. Some evidence also suggests 
that RA signaling interacts with p63 in all three structures, although the exact 
mechanism is still not clear. Malformations of these structures are the main 
hallmarks of p63-related syndromes, which resemble  the phenotype of 
experimentally impaired RA signaling in animal models. Since a large part of the 
evidence on the role of RA is obtained from in vitro and in vivo studies with non-
physiological RA concentrations, care should be taken when extrapolating to 
the physiological functions of RA. Further research in this field will enhance the 
understanding of the regulatory role of RA in the development of  the 
epidermis, the limbs and the secondary palate. This will also contribute to the 
improvement of early diagnosis and prevention of related congenital disorders. 
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correlation between serum RA and serum retinol concentrations 162, 163. Although 
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RA functions during embryonic development, they should be interpreted 
cautiously.   
 
Conclusion 
Current evidence indicates that RA plays a crucial regulatory role in the 
development of the epidermis, the limbs and the secondary palate. This is 
through its direct cellular effects and through its interaction with other 
signalling molecules. Together with other regulatory factors, RA is required to 
initiate the development of epidermis through the induction of proliferation 
and differentiation of embryonic ectodermal cells into epidermal cells. In the 
limbs, proper regulation of RA levels is crucial to initiate limb bud formation 
and to allow chondrogenesis and the transformation of cartilage into bone. 
Moreover, RA-induced apoptosis is required for digit separation. In the palate, 
RA is a key factor in palatal shelf outgrowth, elevation and adhesion, and to 
regulate bone formation in the hard palate. Overall it appears that correct RA 
levels, with respect to location and timing, are crucial for the development of 
the epidermis, the limbs and the secondary palate. Some evidence also suggests 
that RA signaling interacts with p63 in all three structures, although the exact 
mechanism is still not clear. Malformations of these structures are the main 
hallmarks of p63-related syndromes, which resemble  the phenotype of 
experimentally impaired RA signaling in animal models. Since a large part of the 
evidence on the role of RA is obtained from in vitro and in vivo studies with non-
physiological RA concentrations, care should be taken when extrapolating to 
the physiological functions of RA. Further research in this field will enhance the 
understanding of the regulatory role of RA in the development of  the 
epidermis, the limbs and the secondary palate. This will also contribute to the 
improvement of early diagnosis and prevention of related congenital disorders. 
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Abstract 
Retinoic acid (RA) is a key regulator of embryonic development, and linked to 
several birth defects including cleft lip and palate (CLP). The aim was to 
investigate the effects of RA on proliferation and gene expression of human 
palatal keratinocytes (KCs) in vitro. KCs from children with and without CLP 
were cultured with 2 and 5 μM RA. Proliferation was measured by quantification 
of DNA after 2, 4, 6, and 8 days. In addition, we analyzed the effects of RA on 
mRNA expression of genes for proliferation, differentiation, apoptosis, and RA 
receptors. RA similarly inhibited proliferation of palatal KC from cleft and non-
cleft subjects. The proliferation of KCs from cleft subjects was reduced to 59.8 ± 
13.4% (2 μM) and 41.5 ± 14.0% (5 μM, day 6), while that of cells from age-
matched non-cleft subjects was reduced to 66.9 ± 12.1% (2 μM) and 33.9 ± 10.1% 
(5 μM). RA-treatment reduced the expression of several of the investigated 
genes. The proliferation marker PCNA was reduced  in CLP KCs only. Keratins 
10 and 16 were down-regulated in keratinocytes from both cleft and non-cleft 
subjects. p63, a master regulator for epithelial differentiation, was only down-
regulated in KCs from cleft subjects, as was the RXRa receptor. Two p63 target 
genes (GJB6 and DLX5) were strongly down-regulated by RA in all cell lines. 
None of the apoptosis genes was affected. Overall, RA similarly inhibits 
proliferation of palatal KCs from cleft and non-cleft subjects, and reduces the 
expression of specific genes. 
 
  
4 
 
Introduction 
Cleft lip and palate (CLP) is the most common craniofacial birth defect in 
humans and is caused by impaired fusion of the embryonic facial prominences. 
In the aetiology of CLP, both genetic and environmental factors are involved 1. 
One of the most extensively studied environmental factors is maternal 
nutrition. The maternal diet during the first trimester is crucial for the 
development of various organs as well as the orofacial complex 2. An excess or 
deficiency of micronutrients can lead to congenital malformations and is also 
associated with cleft lip and palate 3. Vitamins are of particular interest because 
they cannot be synthesized by the body. They play key roles in growth and 
development and can be considered as vital ingredients of embryonic nutrition 
4. The genetic makeup of individuals  might render higher  sensitivity to vitamin 
excess or deficiency to cause CLP 5-7. 
The fat-soluble vitamin A, or more precisely its derivative retinoic acid (RA), is 
an important regulator of embryogenesis. RA regulates proliferation, 
differentiation, and apoptosis during the morphogenesis of embryonic 
structures 8. RA regulates gene expression through the activation of the RA 
receptors (RARs) and retinoid X receptors (RXRs). These receptors regulate 
their target genes by binding to speciﬁc DNA elements in the regulatory 
regions,  that are called retinoic acid response elements (RAREs) 9-11. RA receptor 
knockout studies have illustrated the importance of RA-signalling in 
palatogenesis. These knockouts exhibit orofacial clefting in addition to the 
agenesis or malformation of other craniofacial structures 4. The developmental 
stage at the time of exposure determines the sensitivity to CLP induction. In 
humans, RA exposure seems most critical between developmental weeks 4 and 
12 12. In this particular period, excessive vitamin A may disturb all three stages of 
palatogenesis; shelf outgrowth, shelf elevation, and shelf fusion 13, 14.  
Keratinocytes (KCs) are known to respond to RA differently in vivo and in vitro. 
In vivo, RA induces the proliferation of basal KCs, and stimulates differentiation 
in higher epidermal layers, resulting in epidermal thickening 15, 16. In vitro, 
however, RA inhibits the proliferation and differentiation of both epidermal and 
oral KCs 17-21. RA can also induce apoptosis in several cancer cell lines, and is 
therefore used in cancer therapies 22-24. In epidermal KCs, RA does not induce 
apoptosis directly, but enhances apoptosis induced by UVB or chemicals 25. 
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receptors (RARs) and retinoid X receptors (RXRs). These receptors regulate 
their target genes by binding to speciﬁc DNA elements in the regulatory 
regions,  that are called retinoic acid response elements (RAREs) 9-11. RA receptor 
knockout studies have illustrated the importance of RA-signalling in 
palatogenesis. These knockouts exhibit orofacial clefting in addition to the 
agenesis or malformation of other craniofacial structures 4. The developmental 
stage at the time of exposure determines the sensitivity to CLP induction. In 
humans, RA exposure seems most critical between developmental weeks 4 and 
12 12. In this particular period, excessive vitamin A may disturb all three stages of 
palatogenesis; shelf outgrowth, shelf elevation, and shelf fusion 13, 14.  
Keratinocytes (KCs) are known to respond to RA differently in vivo and in vitro. 
In vivo, RA induces the proliferation of basal KCs, and stimulates differentiation 
in higher epidermal layers, resulting in epidermal thickening 15, 16. In vitro, 
however, RA inhibits the proliferation and differentiation of both epidermal and 
oral KCs 17-21. RA can also induce apoptosis in several cancer cell lines, and is 
therefore used in cancer therapies 22-24. In epidermal KCs, RA does not induce 
apoptosis directly, but enhances apoptosis induced by UVB or chemicals 25. 
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Since palatal KCs play an important role in the proper fusion of the palatal 
shelves, we hypothesized that the proliferation of palatal KCs from CLP patients 
is more sensitive to RA than that of non-cleft subjects. Therefore, in this study, 
we compared the effects of RA on proliferation and gene expression of palatal 
KCs from CLP patients and age-matched non-cleft subjects in vitro. 
 
Materials and methods 
Keratinocytes 
Palatal KCs (passage 2) were derived from biopsy specimens from the palatal 
mucosa of 4 children with CLP (age 19 ± 1 months) and 4 children without CLP 
(age 26 ± 1 months). The collection of the samples and keratinocyte (KC) culture 
were described previously 26. In brief, the donor children with a cleft were all 
treated in the Cleft Palate Craniofacial Unit of the Radboud university medical 
center. They all had a non-syndromic cleft palate with or without cleft lip and 
alveolus. Control individuals were age-matched children without congenital 
birth defects who were scheduled for tonsillectomy at the Ear-Nose-Throat 
department of the same hospital.  
The Central Ethical Committee of The Netherlands approved the study 
protocol, which included written informed consent from the parents. During 
the primary surgical closure of the cleft palate, a 3 mm biopsy of the palatal 
mucosa was taken in the middle of the hard palate, about 1 cm from the medial 
edge of the cleft. In the non-cleft children, a biopsy was taken during 
tonsillectomy, at about 1 cm from the palatal midline. The KCs were cultured 
from the biopsy samples on a feeder layer of 3T3 cells and stored in liquid 
nitrogen 26. 
 
Cell culture  
For the assessment of proliferation, KCs (passage 3) were cultured in fourfold in 
96-well flat bottom culture plates (8 x 103 cells per well) in 200 μl KGM™ 
Keratinocyte Growth Medium (Lonza), and incubated at 37˚C. KGM was 
composed of keratinocyte basal medium (KBM) supplemented with penicillin 
(100 U/ml), streptomycin (100 U/ml), bovine pituitary extract (0.4%), 
ethanolamine (0.1 mM), phosphoethanolamine (0.1 mM), hydrocortisone (0.5 
6 
 
μg/ml), insulin (5 μg/ml), and epidermal growth factor (10 μg/ml). After 24 
hours of attachment, the cells were cultured for 2, 4, 6 or 8 additional days in 
fresh medium containing 0, 2 or 5 μM all-trans-retinoic acid (RA, Sigma-
Aldrich) and 0.1% dimethyl sulfoxide (DMSO). Medium was changed at days 2, 
4, and 6. RA-containing stock solutions and media were protected from light at 
any time. After culture, the cells were washed with Dulbecco’s Phosphate 
Buffered Saline (DPBS), and digested with papain (0.9 mg/ml) in 0.2 M NaCl, 0.1 
M NaAc, 0.01 M L-cysteine HCL, and 0.05 M EDTA) with pH 6.0 at 60°C to 
liberate the DNA for analysis. Then the samples were centrifuged and frozen at -
20˚C. For the analysis of gene expression, palatal KCs from 4 non-cleft children 
and 4 CLP patients were seeded in twofold in 6-well plates (2.5 x 105 cells per 
well) in 2 ml KGM and incubated at 37˚C. When the cells reached 40-60% 
confluency, they were cultured for an additional 24 hours in medium containing 
2 μM RA and 0.1% DMSO and in medium with DMSO only (control). Then, the 
cells were washed with 1 ml DPBS, and 1 ml TRIzol® Reagent (Invitrogen) was 
added to extract mRNA for the expression analysis. The samples were harvested 
and stored at -80°C. 
 
Cell proliferation assay and DNA quantification  
Cell proliferation was measured by quantification of double-stranded DNA 
using the Quant-iTTM PicoGreen® dsDNA Assay Kit (Invitrogen). Sample 
ﬂuorescence was measured at excitation and emission wavelengths of 485 and 
530 nm (sensitivity 75) using a Bio-Tek® FL600 microplate ﬂuorescence reader 
(Bio-Tek Instruments). DNA concentrations were calculated from a standard 
curve of DNA ranging from 0 to 2000 ng/ml.  
 
Reverse transcription followed by quantitative polymerase chain reaction 
After homogenization with Trizol, chloroform was added, and the sample was 
centrifuged. RNA was extracted from the upper aqueous phase with the RNeasy 
MiniKit (Qiagen). cDNA was generated with 1μg of RNA using the iScriptTM 
Reverse Transcriptase system (Bio-Rad), according to the manufacturer’s 
protocol. Quantitative polymerase chain reaction (qPCR) was performed in 
duplicate in a total reaction volume of 25 μl containing 12.5 μl SYBR® Green 
Supermix (Bio-Rad), 5 μl of cDNA, 4.5 μl of RNAse-free water, 3 μl of 2.5 μM 
forward primer, and 3 μl of 2.5 μM reverse primer. The primers for PCNA, Ki-67, 
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K10, K14, K16, CystatinM/E, Involucrin, p63∆N and -α isoforms, Caspase 3, p53, c-
Jun, RARβ, RXRα, IRF6, CDH3, GJB6, DLX5, DLX6,  GJA1, and hARP were 
obtained from Biolegio (Nijmegen, the Netherlands). All primers are exon-
spanning wherever possible. Primer sequences are provided in Table 1.  
 
Table 1. Primer sequences 
Gene Forward primer Reverse primer 
 
Proliferation 
PCNA TCAGGTACCTCAGTGCAAAAG TGCAAGTGGAGAACTTGGAA 
Ki-67 TGACTTCCTTCCATTCTGAAGAC TGGGTCTGTTATTGATGAGCC 
 
Differentiation 
K10 TGGTTCAATGAAAAGAGCAAGGA GGGATTGTTTCAAGGCCAGTT 
K14 GGCCTGCTGAGATCAAAGACTAC CACTGTGGCTGTGAGAATCTTGTT 
K16 GATCATTGCGGCCACCAT TGCTCATACTTGGTCCTGAAGTCA 
CysM/E TCCGAGACACGCACATCATC CCATCTCCATCGTCAGGAAGTAC 
Involucrin ACTTATTTCGGGTCCGCTAGGT GAGACATGTAGAGGGACAGAGTCAAG 
p63ΔN CAATGCCCAGACTCAATTTAGTGA TGCTGGTCCATGCTGTTCAG 
p63α TCCATGGATGATCTGGCAAGT GCCCTTCCAGATCGCATGT 
 
p63 target genes 
IRF6 TTCTGGTGGACAGATTGAGC AGGGCCATGATATGGAAGAG 
CDH3 CAGGACACCTTCCGAGGGA GGATGGAGTAAGCAACCACCC 
GJB6 CAAGAGGACTTCGTCTGCAAC GGGAAAAAGTGGTCATAGCACA 
DLX5 TTCCAAGCTCCGTTCCAGAC GAATCGGTAGCTGAAGACTCG 
DLX6 GGGGACGACACAGATCAACAA GTCTGCTGAAAGCGATGGTTT 
GJA1 CTGGAACTTATTGGGTGGCAT CCAGCATTCGGAAGATGAAGAG 
 
Apoptosis 
Casp3 GTCGATGCAGCAAACCTCAG CAACACCACTGTCTGTCTCAA 
P53 GCATTCTGGGACAGCCAAGT GCTGTGACTGCTTGTAGATG 
c-Jun GGATCAAGGCGGAGAGGAA TGCAACTGCTGCGTTAGCAT 
 
Retinoid receptors 
RARβ CTCTGTGCATTCTTGCTTCG CCAGGAATCGATGCCAATAC 
RXRα CGCTTGTCAATCAGGCAGT GCTCCTCAGGCAAGCACTAT 
 
Housekeeping gene 
hARP CACCATTGAAATCCTGAGTGATGT TGACCAGCCCAAAGGAGAAG 
 
The cDNA amount was amplified in the C1000TM Thermal Cycler (Bio-Rad), and 
fluorescence was analyzed using the CFX96TM Real-Time System (Bio-Rad). The 
PCR conditions were one cycle at 95˚C for 3 minutes, followed by 39 cycles of 
95˚C for 15 seconds and 60˚C for 30 seconds, and finally a temperature increase 
from 65˚C to 95˚C at 0.5˚C intervals. The amount of gene expression was 
normalized to the expression of mRNA of the human acidic ribosomal protein P0 
(hARP) as a reference gene, and presented as 2-ΔCt. We used hARP as a 
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housekeeping gene because it is more stable in keratinocytes than actin or 
GAPDH 27. The expression of the ∆Np63α isoform was calculated from the 
average expression of the ∆N- and the α-isoform.  
 
Statistical analysis  
The DNA data were calculated as a percentage of the controls without RA 
treatment for each cell line at each time point because of the large individual 
differences. The relative amounts of DNA at each time-point were compared by 
a 2-way ANOVA and a Holm-Sidak post-hoc test to analyze the effects of donor 
type and RA concentration. A value of p<0.05 was considered significant.  
The expression data (2-ΔCt) were calculated as a percentage of the control 
without RA (100%) for each cell line. The effect of RA was then evaluated by a 
one-sample t-test for the difference with 100%. The effect of donor type was 
evaluated by a regular t-test. A value of p<0.05 was considered significant.  
 
Results  
The effects of RA on keratinocyte proliferation 
Palatal keratinocytes from children with and without CLP (henceforth referred 
to as cleft and non-cleft KCs) were cultured with 0, 2, and 5 μM RA. 
Proliferation was measured by quantification of double-stranded DNA after 2, 4, 
6, and 8 days. The cell lines showed a large inter-individual variation in growth 
rate and response to RA (Figure 1A). Some cell lines showed growth acceleration 
after a few days of incubation (NC3 and CLP2). The growth curves seem to 
flatten as cell density increases. In addition, at 2 μM RA, the KCs seem to lose 
their characteristic organization into dense colonies, while, at 5 μM, the cells 
develop an irregular morphology (Figure 1B). No differences were observed 
between cleft and non-cleft KCs. RA inhibited the proliferation of palatal KCs in 
a dose-dependent manner. In order to exclude the individual differences, the 
data from Figure 1 were calculated as a percentage of the controls without RA 
treatment for each cell line. Significant inhibition by 2 μM RA was only observed 
at days 4, 6, and 8 (p<0.05) while the effect of 5 μM RA was significant at all 
days (p<0.05). Only the results for day 6 are shown in detail (Figure 2). In cleft 
KCs, proliferation was reduced to 59.8 ± 13.4% (2 μM, p<0.05) and 41.5 ± 14.0% (5 
μM, p<0.05) at day 6 respectively. The proliferation of age-matched non-cleft 
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KCs was reduced to 66.9 ± 12.1% (2 μM, p<0.05) and 33.9 ± 10.1% (5 μM, p<0.05). 
The differences between cleft and non-cleft KCs were not statistically significant 
at any time-point (p>0.05).  
 
The effects of RA on gene expression  
The expression of all genes was determined after culture with or without 2 μM 
RA for 24 hours. The mRNA levels of the proliferation marker genes PCNA and 
Ki-67 were analyzed in palatal KC obtained from cleft and non-cleft subjects 
(Figure 3A). The expression of PCNA was down-regulated only in cleft KCs after 
RA treatment (p<0.05). The expression of Ki-67 was not affected by RA in both 
cleft and non-cleft KCs. No significant differences between the cleft and non-
cleft KCs were found. 
The expression of several differentiation genes was also analyzed (Figure 3B). 
The expression of K10 and K16 was down-regulated in the RA-treated cells of 
both cleft and non-cleft KCs (p<0.05). Interestingly, only in CLP patients p63 
was down-regulated in RA-treated cells (p<0.05), while the difference between 
the cleft and non-cleft KCs was also significant (p=0.02). The expression of K14, 
Involucrin (INV), and CystatinM/E (CysM/E) was not significantly affected by 
RA. The effect of RA on several genes that are involved in apoptosis is shown in 
Figure 3C. No significant effects of RA on Caspase 3 (Casp3), p53, and c-Jun 
expression were found, but p53 and c-Jun tended to be down-regulated.  
RA might regulate the expression levels of retinoid receptors, and therefore the 
mRNA levels of RARβ and RXRα were analyzed (Figure 3D). RA down-regulated 
the expression of RXRα only in cleft KCs (p<0.05). No significant differences 
between cleft and non-cleft KCs were found. 
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Figure 1. A, Keratinocyte proliferation. KCs from 4 non-cleft children (NC1-NC4) and 4 CLP patients 
(CLP1-CLP4) were cultured for up to 8 days with 0, 2, and 5 μM RA. Then, the DNA content was 
determined. Note the large inter-individual variation in growth rate and response to RA. Also note the 
flattening of the curves if a DNA concentration of around 10 μg/ml is reached. CLP1 was only measured 
until 6 days, as a high number of dead cells was detected at day 8 and therefore excluded. B, 
Keratinocyte morphology. The figure shows representative pictures of the cell cultures at day 6. At 2 μM 
RA, the KCs seem to lose their characteristic organization into dense colonies, while, at 5 μM, the cells 
develop an irregular morphology. No differences were observed between KCs from cleft and non-cleft 
subjects.  
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Figure 2. Relative effect of RA on keratinocyte growth. Growth inhibition of KCs from children with and 
without CLP at day 6 was calculated from the data in figure 1. Because of the large individual differences, 
the effects of 2 and 5 μM RA are shown relative to the control without RA treatment (100%). There was a 
significant effect for both RA concentrations (*, p<0.05), but no significant difference between non-cleft 
and CLP KCs.  
 
Since p63 was down-regulated by RA only in cleft KCs, we also analyzed the 
expression of the p63 target genes IRF6, CDH3, GJB6, and DLX5 (Figure 4). The 
expression of GJA1 and DLX6 was too low for reliable determination (Ct>30). 
The expression of both GJB6 and DLX5 was significantly reduced by RA (p<0.05) 
in cleft KCs as well as non-cleft KCs. 
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Figure 3. The effects of RA on gene expression. KCs from 4 children with CLP and 4 non-cleft children 
were cultured in medium containing 2 μM RA, and in control medium. After a culture period of 24 
hours, mRNA levels for several sets of genes were determined. A, proliferation genes, B, differentiation 
genes; C, apoptosis genes; and D, RA receptor genes. Expression levels are shown as a percentage of the 
controls without RA treatment (100%, dashed lines). (*) represents a significant effect on gene 
expression and (#) indicates a significant difference between cells from CLP patients and non-cleft 
subjects. 
 
Figure 4. The effects of RA on expression of p63 target genes. KCs from 4 children with CLP and 4 non-
cleft children were cultured in medium containing 2 μM RA, and in control medium. After a culture 
period of 24 hours, mRNA levels for several p63 target genes were determined. Expression levels are 
shown as a percentage of the controls without RA treatment (100%, dashed lines). (*) represents a 
significant effect on gene expression. 
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Figure 3. The effects of RA on gene expression. KCs from 4 children with CLP and 4 non-cleft children 
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genes; C, apoptosis genes; and D, RA receptor genes. Expression levels are shown as a percentage of the 
controls without RA treatment (100%, dashed lines). (*) represents a significant effect on gene 
expression and (#) indicates a significant difference between cells from CLP patients and non-cleft 
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Figure 4. The effects of RA on expression of p63 target genes. KCs from 4 children with CLP and 4 non-
cleft children were cultured in medium containing 2 μM RA, and in control medium. After a culture 
period of 24 hours, mRNA levels for several p63 target genes were determined. Expression levels are 
shown as a percentage of the controls without RA treatment (100%, dashed lines). (*) represents a 
significant effect on gene expression. 
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Discussion 
High periconceptional vitamin A intake might disturb crucial cellular processes 
during palatogenesis such as cell proliferation, differentiation and apoptosis 13, 28. 
Epithelia of the palatal shelves play a key role in the fusion of the shelves during 
palate development. Therefore, in the present study we have investigated the 
putative pathogenic effects of RA on palatal KCs from CLP patients and non-
cleft subjects by assessing the effects of RA on the proliferation of palatal KCs. 
In addition, we analyzed the effects of RA on marker genes for proliferation, 
differentiation and apoptosis. Our hypothesis was that the cleft KCs are more 
sensitive to inhibition of proliferation by RA than non-cleft KCs,  which may be 
due to their genetic background. There is evidence that cells from children with 
and without cleft palate are genetically 29 and phenotypically 30 different. 
Individuals with specific polymorphisms of enzymes or other proteins involved 
in vitamin A metabolism might have an increased risk of CLP 6, 7. 
In this study, we found a significant inhibition of keratinocyte proliferation in 
response to RA, which was also previously shown by others 18, 31, 32. Another 
study, using skin KCs from adult donors, did not observe any negative effect of 
RA on keratinocyte growth 20. This might be explained by the different cell type 
and the shorter culture period in the latter study. We also found large inter-
individual variations in growth rate and response to RA between all cell lines. 
This finding was also reported by others 31. Individual differences 
in response to RA may be due to variations in expression of retinoid receptors, 
or polymorphisms in genes involved in RA metabolism. 
We further studied the effects of RA on proliferation by investigating the 
expression of specific marker genes. Despite the clear inhibition of KC 
proliferation in culture, there was no clear effect of RA on the expression of 
proliferation genes. Although the expression of PCNA was significantly reduced, 
that of Ki-67 was not affected. This might be related to the different function of 
these two markers in the cell cycle 33, or to the short culture period. 
Since correct epithelial differentiation is crucial for palatal fusion 28, we also 
studied the effects of RA on several genes related to differentiation. The 
majority of these markers seemed to show a tendency to decrease in RA-treated 
cultures. We observed a significant inhibition of K10 and K16 expression in both 
cleft and non-cleft KCs. K10 is normally expressed in the supra-basal layers of 
skin epithelium and palatal mucoperiosteum. The expression of K10 is known to 
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be down-regulated in proliferating cells 34, which is consistent with our results. 
We also found that K16 is down-regulated in RA-treated cells. K16 is present in 
the supra-basal layers of keratinized oral mucosa, while in epidermis it is 
expressed only in hyperproliferative skin diseases such as psoriasis 35-37. The 
expression of Cystatin M/E, an inhibitor of asparaginyl endopeptidase required 
for envelope maturation 38, was also determined but it showed no change after 
RA treatment. We also analyzed the effects of RA on the expression of p63, 
which encodes a transcription factor that regulates KC proliferation and 
differentiation 39. Interestingly, p63 was the only gene showing a significant 
difference in mRNA levels between cleft and non-cleft KCs. p63 is a key 
regulator of orofacial development and p63 knock-out mice have severe 
developmental impairments 40, 41. Mutations in the human p63 gene cause 
different syndromes in which CLP is one of the major hallmarks 39, 42. The p63 
gene is expressed as multiple isoforms by encoding two different N-termini (TA 
and ΔN) and multiple C-termini (α, β, γ, δ and ε). ΔNp63α, the most 
predominantly expressed p63 isoform in late embryonic and postnatal epithelial 
cells, regulates KC differentiation 43. Therefore, we specifically investigated the 
expression of the ΔNp63α isoform using both ΔN- and α-isoform specific 
primers (see Material and Methods).  Inhibition of p63 expression might lead to 
impaired differentiation of the palatal epithelium and thus prevent palatal 
fusion. In fact, several RAR binding motifs lie near the p63 gene, which might 
explain the inhibition of expression (unpublished data). However, the 
expression of IRF6, which interacts with p63 during palatogenesis in mouse 
embryos was not affected 44. Mutations in this gene cause Van der Woude 
syndrome, of which CLP is one of the phenotypes. The expression of two other 
p63 target genes, GJB6 and DLX5 was reduced by RA. However, this reduction 
was observed in both cleft and non-cleft KCs. GJB6 is involved in epithelial cell 
contacts and, if mutated, can cause ectodermal dysplasia 45. Dlx genes such as 
DLx5, encode for the distalless-related homeodomain transcription factors that 
play key roles in the development and morphogenesis of the head and limb 
skeleton 46. The consequences of down-regulation of these p63 targets by RA for 
keratinocyte physiology and palatogenesis have to be further studied. 
Apoptosis is a crucial process in embryonic development including 
palatogenesis 47. We did not observe a clear effect of RA on apoptosis marker 
genes, but the expression of p53 and c-Jun showed a cautious tendency to 
decrease in both cleft and non-cleft KCs. In future experiments, it might be 
interesting to study the effects of RA on cellular apoptosis during longer culture 
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periods. RA has been reported to induce apoptosis in various cell types such as 
human neuroblastoma cells and rat tracheobronchial epithelial cells 48. In 
addition, RA is shown to enhance the expression of the important apoptosis 
regulators Caspase 3, 6, 7, 9 and p53, in human epidermal KCs treated with UVB 
or doxorubicin 25.  
Further, we observed that RXRα is down-regulated in RA-treated cleft KCs, 
while RARβ tended to be up-regulated in both. RARs and RXRs belong to the 
nuclear receptor superfamily, and mediate the transcriptional activities of RA by 
binding to short DNA sequences (RAREs and RXREs) 19, 49. Both RARs and RXRs 
occur in three different subtypes; α, β and γ, which allows various heterodimer 
combinations. All three RARs are expressed in fetal mouse palate during palatal 
shelf development with increased levels of RARβ 50. RA might regulate the 
expression levels of the receptor mRNA. In our study, RARβ mRNA levels 
showed a weak propensity to increase, which is consistent with another study 
showing that RA up-regulates RARβ in fetal mouse secondary palate both in 
vitro and in vivo 50. RXRα is the most essential RXR isotype during 
embryogenesis, as it  can perform most of the developmental functions of RXRs 
alone 51. The down-regulation of RXRα in CLP patients might reduce RA binding 
and subsequently result in reduced RA function.  
 
Conclusion 
This study shows that RA inhibits the proliferation of KCs from both cleft and 
non-cleft subjects, but with large inter-individual differences. Moreover, the 
expression of some differentiation markers was reduced in the RA-treated 
palatal KCs from both cleft and non-cleft subjects. More detailed studies on the 
effects of RA on the proliferation and differentiation of palatal KCs will provide 
further information on the possible pathogenic effects of RA in the development 
of clefts. 
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Abstract 
Retinoic acid (RA) is one of the key regulators of embryonic development. 
Exposure to high doses of RA, as well as disrupted RA signalling is a risk factor 
for orofacial clefting (OFC). Here, we aimed to investigate the effect of RA on 
expression of OFC-related genes in oral keratinocytes. For this purpose, we 
cultured human oral keratinocytes with and without RA and examined gene 
expression by RNA sequencing analysis. Gene ontology analysis showed that the 
differentially expressed genes are mainly involved in angiogenesis, apoptosis 
and keratinocyte differentiation. A total number of 1402 differentially expressed 
genes were detected of which 15 OFC-related genes were affected at least 1.3-
fold. The fraction of affected OFC-related genes (20.3%) was significantly higher 
than the fraction of affected genes (7%, p<0.0001) of all protein-coding genes. 
Validation by real-time quantitative PCR confirmed the differential expression 
of the majority of these genes. Among the differentially expressed OFC genes, 
SOX9 was consistently up-regulated in both RA-treated gingival and palatal 
keratinocytes. Our results show that OFC genes have increased sensitivity to 
RA, which may contribute to the pathogenesis of OFC. 
 
  
 
4 
 
Introduction   
Retinoic acid (RA) is the biologically active derivative of vitamin A, an essential 
micronutrient for embryogenesis as well as adult homeostasis. Vitamin A cannot 
be synthesized  in the embryo or in the adult body, thus the only source is the 
diet. After ingestion, vitamin A is transformed to RA, one of the key regulators 
of embryonic development.  
Orofacial clefting (OFC) is one of the most common birth defects and  results 
from a failure in one or more stages of palatogenesis 1. OFC is caused by both 
genetic and environmental factors 2. Either aberrant RA signalling 3, 4 or 
excessive doses of RA 5, 6 cause OFC along with other craniofacial 
malformations. This suggests that RA plays a significant role in palate 
development, although the exact cellular and molecular mechanisms are still 
not well-understood.  
Proper functioning of the palatal epithelium is crucial for palatal fusion 7-9. The 
effects of RA on epithelial cells have been mainly studied in epidermal 
keratinocytes. It is now well-established that RA inhibits differentiation 10, 11 and 
induces apoptosis in cultured human epidermal keratinocytes 11, 12. However, the 
in vitro effect of RA on keratinocyte proliferation is inconsistent 13-15 and seems 
to depend  on the culture conditions and experimental setup 16. The effects of 
RA on oral keratinocytes, however, are less studied. A few studies have shown 
that RA inhibits the proliferation and differentiation of both human 17, 18, as well 
as mouse and rat oral keratinocytes in vitro 19, 20. Furthermore, RA has been 
shown to disturb apoptosis and differentiation of the embryonic palatal 
epithelium, which leads to failure of palatal fusion 21, 22. Here, we hypothesize 
that RA has profound effects on the expression of genes involved in palate 
development, and that this may contribute to the pathogenesis of OFC. To test 
our hypothesis, we cultured gingival keratinocytes with and without RA and 
assessed gene expression by RNA sequencing (RNAseq) analysis. Subsequently, 
we focused on a set of genes with known relevance to OFC in order to gain 
insights into the possible mechanism of RA  in the pathogenesis of OFC. Finally, 
we validated the expression of these OFC-related genes by real-time 
quantitative PCR (qPCR) in both gingival and palatal keratinocytes.  
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Materials and Methods 
 
Cell culture 
Gingival tissue samples were obtained during extraction of the third molars with 
informed consent of the patients, which were all around 20 years old. Gingival 
keratinocytes were cultured from gingival tissue samples according to the 
previously reported method 23. For the analysis of gene expression, gingival 
keratinocytes from 7 non-OFC individuals were pooled and seeded in a 6-well 
plate in 2 ml KGM™ Keratinocyte Growth Medium (Lonza) and incubated at 
37˚C. When the monolayer was nearly confluent, cells in 3 wells were cultured 
for an additional 24 hours in medium containing 2μM all-trans-retinoic acid 
(RA, Sigma-Aldrich) and 0.1% dimethyl sulfoxide (DMSO) and the cells in other 
3 wells in medium with DMSO only (control). Palatal keratinocytes were 
obtained from 6 children around 2 years old (3 of them with and the other 3 
without OFC) with informed consent of the parents/caretakers. The study 
protocol was approved by the Dutch Central Ethical Committee on Research 
Involving Human Subjects (CCMO nr Poz.o544C). The cells were seeded in 
twofold in 6-well plates (2.5 x 105 cells per well) in 2 ml KGM and incubated at 
37˚C. When the cells were nearly confluent, they were cultured for an additional 
24 hours in medium containing 2 μM RA and 0.1% DMSO and in medium with 
DMSO only (control). Subsequently, mRNA was isolated using standard 
methods.  
 
cDNA synthesis for real-time quantitative PCR (qPCR) 
cDNA was generated with 1 μg of RNA using the iScript cDNA synthesis Kit 
(Bio-Rad Laboratories), according to the manufacturer’s protocol. Real-time 
quantitative PCR (qPCR) was performed in duplicate in a total reaction volume 
of 25 μl containing 12.5 μl SYBRTM Green Supermix (Bio-Rad Laboratories), 1 μl 
of cDNA, 1 μl of 5 μM forward primer, 1 μl of 5 μM reverse primer and 9.5 μl of 
RNAse-free water. The primers were created using the PrimerQuest tool 24 and 
were analyzed for spanning exon-exon junctions using In-Silico PCR tool of the 
UCSC Genome Browser 25-27, except for SOX4 which possesses only one exon 
(Supplementary table 1). A paired t-test was applied to analyze the differences in 
 
6 
 
expression between treated and non-treated cells using the GraphPad Prism 
software. A value of p<0.05 was considered significant. 
  
cDNA synthesis for RNAseq 
Ribosomal RNA (rRNA) was depleted using the Ribo-Zero Gold rRNA Removal 
Kit (Illumina). RNA was then fragmented into ~200bp fragments by incubation 
for 3 min at 95˚C in the fragmentation buffer [200 mM Tris-Acetate, 500 mM 
Potassium Acetate, 150 mM Magnesium Acetate (pH 8.2)]. First strand cDNA 
synthesis was performed using SuperScript III (Invitrogen), followed by 
synthesis of the second cDNA strand. Library preparation was performed using 
the KAPA Hyper Prep Kit (KAPA Biosystems). Quality of cDNA and the 
efficiency of rRNA removal was confirmed using qPCR with primers for GAPDH 
and 18S rRNA (Supplementary table 3). 
 
Library Preparation for Sequencing 
Illumina library preparation was done using the KAPA Hyper Prep Kit. For end 
repair and A-tailing, double stranded DNA was incubated with end repair and 
A-tailing buffer and enzyme, first for 30 min at 20˚C and then for 30 min at 
65˚C. Subsequently adapters were ligated by adding 30 µl ligation buffer, 10 µl 
DNA ligase, 5 µl diluted adaptor in a total volume of 110 ml and incubated for 20 
min at 15˚C. Post-ligation cleanup was performed using Agencourt AMPure XP 
(Beckman Coulter) and products were eluted in 20µl elution buffer. Libraries 
were amplified by adding 25 µl 2x KAPA HiFi Hotstart ReadyMix and 5 µl 10x 
Library Amplification Primer Mix and PCR program with initial denaturation at 
98˚C for 45 sec, then  8 cycles of denaturation (98˚C for 15 sec), annealing (60˚C 
for 30 sec), extension (72˚C for 30 sec), followed by final extension at 72˚C for 1 
min. Samples were purified using the QIAquick MinElute PCR Purification Kit 
(Qiagen) and 300 bp fragments selected using E-gel  (Invitrogen). Correct size 
selection was confirmed by BioAnalyzer analysis. A qPCR was performed to 
check for any bias. Sequencing was performed using Illumina HiSeq 2000 
machines and generated 43 bp single end reads. 
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Data analysis and identification of differentially expressed OFC genes 
Bioinformatic analysis of the RNAseq data has been performed using standard 
algorithms (Supplementary data, Materials and methods). Genome-wide gene 
ontology (GO) annotation was performed using DAVID Bioinformatics 
Resources 28, 29. The list of 74 OFC-related genes was retrieved from Human 
Phenotype Ontology (HPO)  and Mouse Genome Informatics (MGI) databases. 
The genes from this OFC gene list that were overlapping with differentially 
expressed genes were selected for further validation (Supplementary table 1). 
These genes were then prioritized according to fold change values. A minimum 
1.3-fold change of up- or down-regulation in RA treated cells was used to select 
genes (Supplementary table 2).  
A chi-square test was applied to analyze whether OFC-related genes were 
preferentially affected by RA compared to the total gene list using GraphPad 
Prism software. A value of p<0.05 was considered significant. 
 
Results 
Differentially expressed genes are associated with angiogenesis, 
apoptosis, and keratinocyte differentiation  
In order to analyse the effect of RA on gene expression, we performed RNAseq 
using gingival keratinocytes cultured with and without RA. Following 
bioinformatic analysis (see Supplementary data), we identified 786 up- and 616 
down-regulated genes. Next, we performed gene ontology (GO) analysis to 
evaluate the cellular processes that these genes are involved in. GO analysis 
revealed that many up-regulated genes are involved in angiogenesis, apoptosis, 
wound healing, adhesion, migration and proliferation, whereas the down-
regulated genes are mainly involved in keratinocyte differentiation, epidermal 
development, and wound healing (Figure 1).  
 
 
 
 
8 
 
  
 
Figure 1. Gene ontology analysis of the differentially expressed genes sorted by statistical significance.  
Abbreviations: GO, Gene ontology; (+), positive; (-), negative. 
 
 
A large fraction of OFC-related genes are affected by RA 
In order to analyse whether RA affects the genes involved in the pathogenesis of 
OFC, we searched for differentially expressed genes in a list of 74 OFC-related 
genes reported in HPO and MGI databases (Supplementary table 1). A minimum 
of 1.3-fold change in gene expression was used as the cut-off value. This yielded 
15 differentially expressed OFC genes, 10 of which (ARHGAP29, CASP3, DHCR7, 
FGFR2, LBR, PHC2, SOX4, SOX9, TGFB2 and TGFBR2) were up-regulated and 5 
(GJA1, GRHL3, LMNA, TFAP2 and TP63) were down-regulated by RA 
(Supplementary table 2). In order to analyse whether a larger fraction of the 
OFC-related genes were affected by RA, we applied a Chi-square test. This 
showed that the fraction of affected OFC-related genes (20.3%) was significantly 
higher than the fraction of  all protein-coding genes (7%, p<0.0001). Next, we 
validated the effect of RA on gene expression using qPCR analysis. The 
differential expression of the majority of the genes could be validated, except 
that differential expression of DHCR7, GJA1, LBR, LMNA, TFAP2A and TP63 did 
not reach statistical significance (Figure 2). 
To assess whether RA affects gene expression in a similar fashion in palatal 
keratinocytes, we  performed qPCR for these 15 OFC-related genes in palatal 
keratinocytes with and without RA. The expression of most genes was affected 
by RA in a similar way, although the difference in gene expression was less 
evident (Figure 2). Among these genes, SOX9 was the most strongly up-
regulated gene in palatal keratinocytes, consistent with the up-regulation 
observed in gingival keratinocytes.  
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Data analysis and identification of differentially expressed OFC genes 
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Figure 1. Gene ontology analysis of the differentially expressed genes sorted by statistical significance.  
Abbreviations: GO, Gene ontology; (+), positive; (-), negative. 
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Having identified the OFC genes that were sensitive to RA, we asked whether 
the RA sensitivity of these genes is higher in OFC keratinocytes than in non-
OFC keratinocytes. We hypothesized that the RA sensitivity of these genes is 
higher in OFC keratinocytes. To test this, we compared the expression of these 
genes in palatal keratinocytes derived from non-OFC controls and OFC patients 
in the absence or the presence of RA. We first analysed the effects of RA on the 
expression of these 15 genes in pooled non-OFC and OFC keratinocytes. We 
observed a similar effect of RA on gene expression in both OFC and non-OFC 
keratinocytes, except for the expression of TP63 and FGFR2. The expression of 
TP63 and FGFR2 seemed to be more strongly down-regulated in OFC 
keratinocytes than in non-OFC keratinocytes (Figure 3A). To further validate 
the difference, we then analyzed the effect of RA on the expression of TP63 and 
FGFR2 in three independent OFC and  non-OFC keratinocyte lines. This 
demonstrated that the expression of TP63 was indeed significantly more down-
regulated in RA-treated OFC cells than in RA-treated non-OFC cells. However, 
this was not confirmed for FGFR2 (Figure 3B). 
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Figure 2. RNAseq results and qPCR validation of the differentially expressed OFC-related genes in 
gingival and palatal keratinocytes. A, fold-change of genes up-regulated by RA. B, fold change of genes 
down-regulated by RA. Error bars represent SD of biological replicates (n=3). Fold changes are always in 
comparison to the corresponding sample without RA, which is represented by the dashed line. GKC, 
gingival keratinocytes; PKC, palatal keratinocytes; *, statistical significance between RA-treated and 
untreated samples (p<0.05). 
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Figure 3. Differential gene expression in RA-treated OFC and non-OFC palatal keratinocytes. A, gene 
expression in pooled non-OFC and OFC palatal keratinocytes. Error bars indicate the SD of the technical 
duplicates; B, expression of FGFR2 and TP63 in independent non-OFC and OFC palatal keratinocytes. 
Error bars indicate the SD of the independent cell lines (n=3); Fold changes are always in comparison to 
the corresponding sample without RA, which is represented by the dashed line. PKC, palatal 
keratinocytes; *, statistical significance between RA-treated and untreated samples (p<0.05). 
 
 
Discussion  
The present study shows that genome-wide 786 genes are up- and 616 genes are 
down-regulated by RA in gingival keratinocytes. GO analysis of the up-regulated 
genes revealed a significant enrichment for genes involved in angiogenesis, 
apoptosis, wound healing, adhesion, migration and proliferation. This is in line 
with previous experimental data showing that RA is a key regulator of 
angiogenesis in early mouse embryos 30, 31. Furthermore, RA is known to induce 
apoptosis in both human 11, 12 and mouse epidermal keratinocytes 32, 33. Genes 
involved in wound healing, adhesion, migration and proliferation are also up-
regulated by RA, but to a lesser degree. GO analysis of down-regulated genes 
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revealed a significant enrichment for genes involved in keratinocyte 
differentiation. This is in line with previous reports that RA inhibits 
differentiation of cultured human epidermal 10, 11 and oral keratinocytes 18. Taken 
together, our RNAseq data provide new evidence at the transcriptomic level that 
RA regulates angiogenesis and apoptosis, and inhibits differentiation of oral 
keratinocytes.   
Interestingly, we found that RA preferentially affects  OFC-related genes. This 
prompted us to focus on further analyses of these genes. TGFB2 and TGFBR2, 
both up-regulated by RA, mediate TGFβ signalling which is a major regulator of 
cell growth and apoptosis in various cell types including epithelial cells 34. In 
epithelial cells, TGFβ inhibits cell growth through cell cycle arrest and apoptosis 
35. Consistent with our data, RA has been shown to induce TGFB2 expression 
leading to growth inhibition of cultured human and mouse epidermal 
keratinocytes 36, 37. Furthermore, earlier reports showed that RA induces 
caspase-3 expression in vitro leading to apoptosis in epidermal keratinocytes 12, 
38. TGFB2 has also been shown to inhibit human epidermal keratinocyte 
differentiation 39. Similar to TGFB2, SOX9 also inhibits epidermal keratinocyte 
differentiation 40. On the other hand, GHRL3, which is down-regulated by RA, 
can enhance both embryonic and postnatal keratinocyte differentiation in mice 
41, 42. Thus, our expression data are in agreement with previous findings that RA 
induces growth inhibition and apoptosis in oral keratinocytes, and inhibits 
differentiation.  
In addition, differentially expressed OFC-genes such as TGFB2, TGFBR2, 
ARHGAP29, FGFR2, GHRL3 and SOX9 are related to proliferation, migration and 
adhesion. In contrast to the growth inhibitory effect of TGFβ signalling, both 
SOX9 and FGFR2, which are also up-regulated by RA, induce keratinocyte 
proliferation 40, 43. The up-regulation of both inhibitory and stimulatory genes 
suggests a complex RA control of proliferation. However, both TGFβ and FGF 
signalling enhance keratinocyte migration 44, 45 through activation of Rho 
GTPases Rac1, Cdc42, and RhoA 46, 47. Our data on TGFB2, TGFBR2 and FGFR2 
expression suggest that RA stimulates keratinocyte migration. However we also 
observed up-regulation of genes that inhibit migration. That is, ARHGAP29 
which is up-regulated by RA, inactivates RhoA 48, whereas GHRL3, which is 
down-regulated by RA, activates RhoA 49. Since RhoA is essential for 
keratinocyte migration 50, either up-regulation of ARHGAP29 or down-
regulation of GHRL3 by RA would inactivate RhoA and inhibit migration. This 
indicates a rather complex regulation of migration by RA, possibly in 
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conjunction with other co-regulatory factors.  Furthermore, genes that stimulate 
cell adhesion show an opposite response to RA, e.g. GRHL3 44 that is down-
regulated and FGFR2 42 that is up-regulated. Our analyses of OFC genes involved 
in proliferation, migration and adhesion suggest that RA plays a complex role in 
regulating these processes. This might explain the inconsistent data on RA 
effects in previous studies.  
We also investigated whether OFC genes in palatal keratinocytes from OFC 
patients are more sensitive to RA than those from non-OFC controls. Our 
preliminary analysis revealed that the expression of TP63 is more strongly 
down-regulated in RA-treated OFC keratinocytes compared to non-OFC 
keratinocytes, which is consistent with our previous report 17. In other words, 
TP63 expression is more sensitive to RA in OFC keratinocytes, which suggests a 
stronger link between RA and p63 in OFC keratinocytes. Previously, it has been 
shown that RA regulates the expression of TP63 in epithelial cells and that p63 
also regulates RA biosynthesis (reviewed in 51). Possibly, genetic variations in 
p63 pathway or RA metabolism and signalling in OFC patients might affect the 
interaction between these two molecules. 
In summary, our data demonstrate that RA preferentially affects the expression 
of OFC-related genes in oral keratinocytes. The affected OFC-related genes 
promote apoptosis and inhibit differentiation. In addition, genes involved in 
proliferation, migration and adhesion are affected by RA in a more complex 
manner. Understanding the mechanism behind the interaction of RA with these 
genes might shed light on the role of RA in the of pathogenesis OFC.  
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Supplementary data materials and methods  
 
Bioinformatic analysis of RNAseq data  
STAR (version 2.5.1) 1, 2 package with default settings was used to align the 
fragments to the human reference genome (hg19, Feb 2009). Both CuffDiff 3 
(part of cufflinks 2.2.1 package) and DEseq2 4 packages in R were used with 
default settings to obtain differential gene expression in RA-treated and 
untreated gingival keratinocytes. A Pearson’s correlation coefficient heat map 
representing the similarity between samples was created along with principle 
component analysis plot in R with ggplot2 package (http://ggplot2.org/). A 
FPKM (Fragments Per Kilobase of transcript per Million mapped reads) 
threshold plot was calculated for the CuffDiff output by using a normal 
distribution of the FPKM values via a histogram in R using ggplot2 package. The 
genes detected by both CuffDiff and DEseq2 were selected for further validation. 
Venn diagrams were created for the differentially regulated genes for both 
programs (http://bioinformatics.psb.ugent.be/webtools/Venn/). 
 
Quality control of the RNAseq data 
Approximately 26.000.000 reads were obtained for each RNAseq sample 
assigned to 63652 genes [detected via STAR (version 2.5.1)1, 2], with percentages 
of uniquely mapped reads ranging from 69% to 75%, which shows that the 
quality of RNAseq was reliable and appropriate for further analysis. Two 
independent programs, CuffDiff 3 and DESeq2 4, were applied to 19957 protein-
coding genes to detect differentially expressed genes. In order to obtain a 
reliable differentially expressed gene list, the genes that were detected by both 
programs were selected for further analysis (Supplementary figure 1). Because 
the p value calculation of CuffDiff was more stringent in comparison to DESeq2, 
a more stringent p value conditions were applied to DESeq2 (from p<0.05 to 
p<0.01), totalling to 792 up-regulated and 660 down-regulated genes in the RA 
treated condition. 
Pearson’s correlation coefficient analysis showed that the biological replicates 
within either RA-treated or untreated samples were closely correlated. However, 
the correlation between RA-treated and untreated samples was weak 
(Supplementary figure 2A). The principle component analysis showed that the 
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treated and untreated samples were clearly separated along the PC1 axis that 
accounts for 82% of the variance (Supplementary figure 2B). The frequency 
histogram reveals log2-transformed FPKM values distributed between two 
peaks. A threshold was designed to mark the lowest frequency between the two 
peaks. We used a 0.4 FPKM (Fragments Per Kilobase of transcript per Million 
mapped reads) cut-off that generated a list of 786 up-regulated and 616 down-
regulated genes that were most probable of being truly expressed based on the 
FPKM values (Supplementary figures 2C and 3). 
 
Supplementary figure 1. Differentially expressed genes detected by both DESeq2 and CuffDiff 
programs. A value of p<0.01 was applied to DESeq2 in order to restrain the amount of differentially 
expressed genes. 
 
 
20 
 
 
 
Supplementary figure 2. Quality control of the RNAseq data. A, PCC heat map with gradient of 
correlation going from black (strongly correlated) to white (non-existent/very weak correlation); B, PCA 
plot; C, Frequency histogram of log2-transformed FPKM values for RA-treated and untreated GKC. The 
genes with significant base level expression and fewer false positives were represented to the right of the 
FPKM cut-off.  
Abbreviations: GKC, gingival keratinocytes; FPKM, Fragments Per Kilobase of transcript per Million 
mapped reads; PCA, principal component analysis; PCC, Pearson’s correlation coefficient; RA, retinoic 
acid. 
 
 
Supplementary figure 3. Venn’s diagram of the differentially expressed genes following FPKM cut-off 
application. 
Abbreviations: FPKM, Fragments Per Kilobase of transcript per Million mapped reads  
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Supplementary table 1. The list of 74 OFC-related genes retrieved from the Human Phenotype 
Ontology (HPO) and Mouse Genome Informatics (MGI) databases. The genes overlapped with the 
RNAseq data and selected for further analysis are typed in bold. 
 
1. ACAN 2. FGF18 3. MDM2 4. SDCCAG8 
5. ACVR1 6. FGFR2 7. MKS1 8. SEMA3E 
9. ALX4 10. FIGN 11. MMP16 12. SIM2 
13. ARHGAP29 14. FST 15. MN1 16. SLC26A2 
17. B3GALTL 18. GBX2 19. NCOR2 20. SOX4 
21. BMPER 22. GJA1 23. NEK1 24. SOX5 
25. BNC2 26. GLI2 27. NIPBL 28. SOX9 
29. BRAF 30. GPC3 31. PBX1 32. SPECC1L 
33. CASK 34. GPR124 35. PHC2 36. SPRY2 
37. CASP3 38. GRHL3 39. PKDCC 40. TACC3 
41. CHD7 42. GSK3B 43. PNN 44. TBX1 
45. COL2A1 46. GTF2IRD1 47. PTCH1 48. TBX2 
49. CTNNB1 50. HOXA1 51. PTPN11 52. TBX3 
53. DHCR7 54. INHBA 55. PVRL1 56. TFAP2A 
57. DLG1 58. KAT6A/ MYST3 59. RDH10 60. TGFB2 
61. EDNRA 62. KCNJ2 63. ROR2 64. TGFBR1 
65. EFNA5 66. LBR 67. RPGRIP1L 68. TP63 
69. EXT1 70. LMNA 71. RPL38  
72. FBXW7 73. LUZP1 74. RYK  
 
 
 
Supplementary table 2. Overview of the differentially regulated OFC-related genes in RA-treated and 
untreated gingival keratinocytes with a minimum of 1.3-fold change and following the computational 
analysis (CuffDiff and DESeq2).  
Abbreviations and symbols: RA, retinoic acid, ↑, up-regulation; ↓, down-regulation. 
 
Differentially 
regulated genes 
Expression Fold change 
RA- RA+ CuffDiff DESeq2 
1 SOX9 ↑ 1.3 5.9 4.39 4.20 
2 PHC2 ↑ 14.1 27.7 1.97 1.93 
3 CASP3 ↑ 19.2 39.2 1.96 1.80 
4 TGFB2 ↑ 8.0 14.4 1.80 1.86 
5 SOX4 ↑ 25.8 25.1 1.59 1.60 
6 FGFR2 ↑ 6.2 9.8 1.58 1.58 
7 TGFBR2 ↑ 14.9 23.0 1.54 1.56 
8 LBR ↑ 9.2 13.9 1.50 1.33 
9 DHCR7 ↑ 30.8 43.2 1.40 1.48 
10 ARHGAP29 ↑ 8.2 11.3 1.38 1.39 
11 GRHL3 ↓ 13.0 4.6 0.35 0.36 
12 TFAP2A ↓ 6.8 4.1 0.61 0.62 
13 LMNA ↓ 301.9 183.6 0.61 0.61 
14 GJA1 ↓ 68.9 46.8 0.68 0.70 
15 TP63 ↓ 61.8 46.9 0.76 0.74 
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Supplementary table 3. Primer sequences 
Gene Forward primer Reverse primer 
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
18s rRNA GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 
ARHGAP29 TTGGACCTGCCAACTCTTTAG CGATGAAAGTCTCCTGGACTTATAG 
CASP3 AGACAGACAGTGGTGTTGATG ATAATAACCAGGTGCTGTGGAG 
DHCR7 GGTGTGCGCAGGACTTTA GTCATTGGTGACGCCATCT 
GJA1 CAATCACTTGGCGTGACTTCA ACCTTGTCAAGGAGTTTGCCTAA 
GRHL3 TCCCAAGGAGAAGCGGATAT GCTTTCAAGGGGAGTGAGGT 
LBR GATGCTCTCTGGAATGAGGAAG TTTGCACCTCGGAAGATTACA 
LMNA CCAGAAGAACATCTACAGTGAGG TGTCCAGCTTGGCAGAATAA 
PHC2 GGTTCCTGCCTGAGAAACTT CACCCTCCTCTTTGGATTCTTG 
SOX4 CTCTCCAGCCTGGGAACTATAA CGGAGGTGGGTAAAGAGAGAA 
SOX9 GAACAAGCCGCACGTCAA GCTCTCGTTCAGAAGTCTCCA 
TFAP2A CACCTCGAAGTACAAGGTCAC GGACAGCTTCTCCCTCTACTA 
TGFB2 CGGCCTATTGCTTTAGAAATGT TACCCTTTGGGTTCGTGTATC 
TGFBR2 GCCCATCCACTGAGACATATT TCTCGTCATTCTTTCTCCATACAG 
TP63 CAATGCCCAGACTCAATTTAGTGA TGCTGGTCCATGCTGTTCAG 
Housekeeping gene   
HARP CACCATTGAAATCCTGAGTGATGT TGACAAGCCCAAAGGAGAAG 
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Abstract 
Orofacial clefts (OFC) are among the most frequent craniofacial birth defects in 
humans with a significant impact on quality of life and psychosocial 
development. OFC occur as a result of deviations in one or more stages of 
palatogenesis. Cell proliferation, differentiation, adhesion, migration and 
apoptosis play crucial roles in palatogenesis and require a tight regulation. We 
hypothesized that gene deregulation in oral epithelial keratinocytes affects  
these processes and  contributes to the pathogenesis of  OFC. We performed 
microarray expression analysis on palatal keratinocytes derived from OFC and 
non-OFC individuals. Principal component analysis showed a clear difference in 
gene expression between the two cell types, with 24 and 17% for the first and 
second component respectively. In OFC cells, 228 genes were differentially 
expressed compared with non-OFC cells (p<0.001). Gene ontology analysis 
revealed an enrichment of genes involved in β1 integrin-mediated adhesion and 
migration, as well as in other adhesion-related signaling pathways such as P-
cadherin. Both β1 integrin and P-cadherin were clearly expressed in the palatal 
epithelium from OFC and non-OFC individuals. Our data indicate that adhesion 
and migration are impaired in OFC keratinocytes. Finally, a scratch assay 
demonstrated significantly reduced migration of OFC keratinocytes (343.6 ± 
29.62 μm) vs. non-OFC keratinocytes (503.4 ± 41.81 μm, p<0.05). Hence, our 
results indicate that adhesion and migration programs are deregulated in OFC 
keratinocytes, which might be relevant to OFC pathogenesis. 
 
  
Introduction 
Orofacial clefting (OFCs) is among the most frequent congenital anomalies with 
a frequency of about 8 per 10,000 live births worldwide 1. OFC not only causes 
functional problems pertaining to feeding, hearing, speech, and dental 
functioning, but also negatively affects facial appearance, psychosocial wellbeing 
and social integration. The majority of OFC occurs as an isolated disorder, 
however OFC can also be a part of a syndrome 2. Genetic as well as 
environmental factors contribute to the aetiology of OFC. 
Development of the secondary palate involves sequential processes of palatal 
shelf outgrowth, elevation, adhesion and fusion. Disruption in one or more of 
these processes can give rise to OFC 3. The embryonic oral cavity is lined with 
the periderm, a single layer of flattened epithelial cells covering the embryonic 
epithelia 4. This provides a non-sticking barrier to prevent aberrant epithelial 
adhesions 5. Prior to contact of the palatal shelves, periderm cells disappear 
through desquamation 6, 7 and possibly also through migration to the oral and 
nasal side of the palatal shelves 8, 9 exposing the midline edge epithelium (MEE). 
The exposed MEE cells then differentiate into bulging cells with lamellipodia 
and filopodia 10, 11 and adhere to the opposing MEE at the midline. Following 
adhesion, the midline epithelial seam (MES) is formed. The MES eventually 
disappears to allow mesenchymal continuation across the palate. Apoptosis and 
migration are believed to play the major role in the MES disappearance 7, 12, 
whereas role of epithelial-mesenchymal transition remains controversial. Taken 
together, correct epithelial functioning is crucial for  palatal fusion.   
Previously, cultured human palatal fibroblasts derived from OFC patients have 
shown to exhibit an abnormal phenotype with respect to ECM synthesis, 
expression of TGFβ isoforms, and response to retinoic acid compared with non-
OFC palatal fibroblasts 13-15. However, studies on differences between non-OFC 
vs. OFC palatal keratinocytes are lacking. Here, we hypothesized that genes 
related to crucial cellular processes involved in palatogenesis such as 
proliferation, migration, adhesion, differentiation and apoptosis are deregulated 
in keratinocytes derived from OFC patients. To test our hypothesis, we firstly 
performed microarray analysis on palatal keratinocytes obtained from OFC 
patients (further referred to as OFC keratinocytes) and non-OFC individuals 
(further referred to as non-OFC keratinocytes). Gene ontology (GO) analysis 
revealed enrichment of genes involved in adhesion and migration. The 
expression of these genes was then validated with qPCR in both affected and 
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Orofacial clefts (OFC) are among the most frequent craniofacial birth defects in 
humans with a significant impact on quality of life and psychosocial 
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disappears to allow mesenchymal continuation across the palate. Apoptosis and 
migration are believed to play the major role in the MES disappearance 7, 12, 
whereas role of epithelial-mesenchymal transition remains controversial. Taken 
together, correct epithelial functioning is crucial for  palatal fusion.   
Previously, cultured human palatal fibroblasts derived from OFC patients have 
shown to exhibit an abnormal phenotype with respect to ECM synthesis, 
expression of TGFβ isoforms, and response to retinoic acid compared with non-
OFC palatal fibroblasts 13-15. However, studies on differences between non-OFC 
vs. OFC palatal keratinocytes are lacking. Here, we hypothesized that genes 
related to crucial cellular processes involved in palatogenesis such as 
proliferation, migration, adhesion, differentiation and apoptosis are deregulated 
in keratinocytes derived from OFC patients. To test our hypothesis, we firstly 
performed microarray analysis on palatal keratinocytes obtained from OFC 
patients (further referred to as OFC keratinocytes) and non-OFC individuals 
(further referred to as non-OFC keratinocytes). Gene ontology (GO) analysis 
revealed enrichment of genes involved in adhesion and migration. The 
expression of these genes was then validated with qPCR in both affected and 
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unaffected cells. Finally, our scratch assay confirmed that migration of OFC 
keratinocytes was reduced in comparison with non-OFC keratinocytes. 
 
Materials and methods 
Subjects and tissue sampling 
The OFC group  consisted of 15 children, 10 males and 5 females (age 1.5 ± 0.2 
years) with non-syndromic cleft palate (with or without cleft lip and alveolus). 
The OFC group contained 5 subjects with cleft palate only and 10 subjects with 
cleft lip and palate. The non-OFC control group consisted of 7 males and 8 
females (age 1.9 ± 0.4 years) without congenital malformations. All subjects gave 
their informed consent. In the OFC group, 3 mm-biopsies of the hard palate 
mucosa were taken about 1 cm from the medial edge of the cleft during the 
primary surgical closure. In the non-OFC group a similar biopsy was taken 
during tonsillectomy at about 1 cm from the midline of the hard palate. Palatal 
keratinocytes were cultured from the biopsy specimens according to a 
previously reported method 16. The study protocol was approved by the Central 
Ethical Committee of The Netherlands (Poz.o544C). 
 
Cell culture 
For the microarray assay, palatal keratinocytes (passage 3) were thawed and 
cultured in T75 flasks in 10 ml keratinocyte serum free medium (K-SFM) (Gibco, 
Invitrogen) with supplements and incubated at 37°C. Once the cells reached 80-
90% confluence, they were cultured for an additional 24 hours in fresh medium. 
Subsequently, the cells were washed with cold phosphate-buffered saline (PBS), 
lysed in RLT buffer (RNeasy Mini Kit®) containing β-mercaptoethanol, and 
stored at -80°C.  
 
RNA isolation and microarray expression analysis 
Total RNA was extracted using the RNeasy Mini Kit® (Qiagen) according to the 
manufacturer's protocol and quantified spectrophotometrically. Sample quality 
was analysed using the Agilent 2100 Bioanalyzer® (Agilent Technologies). RNA 
was pooled randomly into 5 pools of 3 non-OFC or 3 OFC subjects. Each pool 
contained the same amount of RNA from each cell line. 6 μg RNA from each 
pool was used for cDNA synthesis. 10 μg labeled cDNA was hybridized to 
Human Genome U133 Plus 2.0 Array® (Affymetrix) according to the 
manufacturer’s protocol at the Department of Human Genetics, Radboud 
Institute of Molecular Sciences, Nijmegen, The Netherlands. Arrays were 
scanned with a GeneChip® Scanner 3000 (Affymetrix).  
Affymetrix CEL files were imported into Affymetrix Expression Console version 
1.1. Control probes were subsequently extracted using the default RMA 
algorithm for quality analysis. The area under the curve (AUC) of the receiver 
operator characteristic was calculated using the positive and negative control 
probes. All arrays had a AUC score above the empirically defined threshold of 
0.85 indicating a good separation of the positive controls from the negative 
controls. Subsequently, CEL files were imported into Partek (Partek Genomic 
Suite software, version 6.4; Partek Inc.) where only core exons were extracted 
and normalized using the RMA algorithm with GC background correction. Core 
transcript summaries were calculated using the mean intensities of the 
corresponding probe sets 17. Principal component analysis was used as quality 
control and was performed with the python package scikit-learn, version 0.17.1 
(http://scikit-learn.org). Samples were divided in two groups, OFC patient cells 
and non-OFC controls. A paired t-test was performed on the 2log intensities. 
The fold changes between OFC and non-OFC samples were calculated from 
these data. Gene Ontology (GO) analysis was performed on differentially 
regulated genes (p<0.001) using DAVID Bioinformatics Resources website 18, 19. 
Expression differences for genes of interest were subsequently validated using 
qPCR. 
 
Reverse transcription and real-time quantitative PCR 
cDNA was synthesized from 1 μg total RNA using the SuperScript® II Reverse 
Transcriptase (Invitrogen) according to the manufacturer’s protocol and 
followed by digestion with the Deoxyribonuclease I, Amplification Grade® 
(DNase I, Amp Grade) (Invitrogen). Real-time quantitative PCR (qPCR) was 
performed in duplicate in a total reaction volume of 25 μl containing 12.5 μl 
SYBR Green Supermix® (Bio-Rad Laboratories), 5 μl of cDNA, 4.5 μl of RNAse-
free water, 3 μl of 2.5 μM forward primer, and 3 μl of 2.5 μM reverse primer. All 
primers were designed with exon spanning wherever possible and were obtained 
from Biolegio® (Nijmegen, the Netherlands). Primer sequences are provided in 
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Supplementary table 1. The cDNA amount was amplified in the C1000 Thermal 
Cycler® (Bio-Rad Laboratories), and fluorescence was analysed using the CFX96 
IVD Real-Time PCR System® (Bio-Rad Laboratories). The PCR conditions were 
one cycle at 95°C for 3 minutes, followed by 39 cycles of 95°C for 15 seconds and 
60°C for 30 seconds, and finally a temperature increase from 65°C to 95°C at 
0.5°C intervals. The gene expression was normalized to that of human acidic 
ribosomal protein P0 (hARP), and presented as 2−ΔCt. We used hARP as a 
housekeeping gene because it is more stable in keratinocytes than actin or 
GAPDH 20. 
Initial statistical analysis revealed that the expression values of two non-OFC 
(C4 and C13) and two OFC (H196 and H247) cell lines deviated more than two 
standard deviations from the mean for the majority of the genes. Therefore, 
these four cell lines were excluded for the final analysis. The expression values 
of CDH3 and THBS1 were 10log transformed because of non-normal distribution. 
The difference between the expression of the candidate genes in OFC cells and 
non-OFC cells was tested with an unpaired t-test. A value of p<0.05 was 
considered significant. 
 
Immunostaining of tissue samples 
Tissue samples were fixed for 4 hours  in 4% paraformaldehyde in 0.1 M 
phosphate buffer at room temperature and embedded in paraffin. Serial sections 
(5 µm) were cut, mounted on Superfrost-Plus slides (Menzel-Gläser), 
deparaffinated and rehydrated. Immunohistochemical staining was performed 
using the avidin-biotin-peroxidase complex method. For the β1 integrin 
staining, sections were pre-treated with 0.1% trypsin (Sigma-Aldrich) in PBS for 
antigen retrieval. For the P-cadherin staining an additional microwave 
treatment in citrate buffer was performed. Then the sections were incubated 
with a biotinylated secondary antibody (Jackson ImmunoResearch). 
Subsequently, the avidine-biotin complex was applied. Finally, the sections were 
stained with a di-amino benzidine  solution (Sigma-Aldrich) and counterstained 
with Mayer’s haematoxylin. 
 
 
 
Scratch assay 
Palatal keratinocytes were cultured in triplicate in 24-well flat bottom plates 
(1105 cells/well) and incubated at 37 °C. When cells reached confluence, the 
monolayer was scratched with a p-200 pipette tip to create two uniform cell-free 
lines of 843 ± 9 μm width in each well crossing each other at a 90° angle (Figure 
2B). After removal of the detached cells by gently washing with PBS, the 
adherent cells were incubated in K-SFM without supplements for 16 hours to 
observe migration. After 16 hours, the cells were washed with PBS three times, 
and fixed with 4% paraformaldehyde at room temperature for 30 minutes. Then 
cells were washed three times with ddH2O and stained with 0.1% crystal violet 
at room temperature for 30 minutes. The cells were washed again three times 
with ddH2O and were dried in the hood. The width of the scratches was 
measured at 12 locations in each well using a Leica MZ12 microscope® (Leica 
Microsystems) equipped with a digital camera, as illustrated in Figure 2B.  
The mean migration distance was determined for each well and the mean with 
standard deviation was calculated for the three replicate wells. The difference 
between the original width of the scratch and the width after 16 hours was 
expressed in m. The mean migration was calculated as the mean difference 
between the original width of the scratch and the width after 16 hours. 
Subsequently, the difference between OFC and non-OFC samples was tested by 
an unpaired t-test. A value of p<0.05 was considered significant.  
 
Results 
Microarray analysis  
The Human Genome U133 Plus 2.0 Array (Affymetrix) covering over 47,000 
transcripts has been used for the microarray analysis. PCA analysis showed a 
clear difference in gene expression between the two cell types, with 24% and 
17% for the first and second component respectively (Figure 1). From the 228 
genes with a differential expression (p<0.001), 50 genes were up-regulated and 
178 genes were down-regulated in OFC keratinocytes vs. non-OFC 
keratinocytes. 
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Figure 1. PCA analysis of microarray data from OFC and non-OFC cells. The first and second 
component were responsible for 24% and 17% of the difference respectively. 
 
 
Gene ontology analysis 
In order to analyze the functional annotation of the 228 differentially expressed 
genes we performed GO analysis using the DAVID Bioinformatics Resources 
website 18, 19. GO analysis showed an enrichment of genes related to adhesion 
and migration. Next, we used Endeavour software 21, 22 to identify more genes 
involved in adhesion and migration. This analysis resulted in 21 genes 
(ARHGAP26, CDH3, DOCK5, DST, EGFR, FBLIM1, ITGA3, ITGB4, JAK1, LAMA3, 
LAMC1, LPP, MICAL2, MLLT4, PARVA, PXN, SMAD7, THBS1, TNC and TNS3), all 
down-regulated in OFC keratinocytes vs. Non-OFC keratinocytes. Table 1 
summarizes the statistical analysis and the raw array data of these genes. 
 
Validation of the prioritized genes 
Among the final 21 genes, 4 genes (ARGHAP26, DOCK5, SMAD7 and TNS3) are 
hardly expressed in keratinocytes (data not shown), and were not studied 
further. We performed qPCR analysis to validate the remaining 17 genes. 6 genes 
(CDH3, ITGB1, JAK1, LAMA3, THBS1 and TNC) were significantly down-regulated 
in OFC-keratinocytes vs. Non-OFC keratinocytes. The validation of LPP was 
considered not reliable due to high Ct values (>30). The results of the qPCR 
validation are presented in Figure 2.  
 
Table 1. Gene expression.  
Mean non-OFC and Mean OFC represent average relative expression in non-OFC and OFC cells 
respectively. * indicates statistically significant differentially expressed genes validated by qPCR. 
 
Down-regulated  
genes 
Statistical analysis Relative expression 
Mean 
(Non-
OFC) 
Mean 
(OFC) 
Fold 
change 
P 
value 
Non-OFC pools OFC pools 
1 2 3 4 5 1 2 3 4 5 
1 ITGB1* 5418 4338 1.249 0.0001 5569 5238 5682 5430 5173 4373 4020 4553 4247 4497 
2 FBLIM1 384.9 257.2 1.496 0.0001 352.7 408.1 369.9 373.9 419.9 256.0 291.9 228.8 236.9 272.4 
3 EGFR 480.9 347.1 1.385 0.0002 477.4 524.3 492.5 434.1 476.7 302.6 378.9 342.2 337.1 375.0 
4 DST 228.8 163.6 1.398 0.0003 245.8 233.0 218.8 205.5 241.0 173.5 184.5 151.9 143.3 165.0 
5 ITGB4 2554 1847 1.383 0.0003 2621 2574 2562 2373 2639 1556 1922 2030 1705 2022 
6 CDH3* 5647 3979 1.419 0.0004 6111 5235 5758 5068 6065 3500 3786 4079 3917 4615 
7 TNC* 3192 1797 1.776 0.0006 3253 3999 3315 2345 3048 1516 1883 2134 1659 1792 
8 DOCK5 88.24 64.72 1.363 0.0006 75.01 89.50 95.31 83.75 97.62 60.40 69.22 64.30 69.36 60.36 
9 ITGA3 696.1 500.5 1.391 0.0007 658.8 739.0 684.0 708.1 690.9 442.2 600.0 523.9 430.8 505.6 
10 LPP 111.9 85.60 1.307 0.0007 131.0 114.5 110.5 103.6 100.1 83.58 87.08 85.04 81.84 90.50 
11 JAK1* 196.8 157.7 1.248 0.0007 199.8 183.2 196.9 197.7 206.6 143.4 161.6 177.7 158.3 147.6 
12 MLLT4 827.1 613.0 1.349 0.0008 837.3 883.1 885.4 706.3 823.5 526.6 659.3 637.7 629.9 612.0 
13 SMAD7 126.4 95.05 1.330 0.0009 139.3 126.8 133.0 116.7 116.3 92.49 85.72 107.5 101.9 87.74 
14 LAMC1 1263 1066 1.185 0.0026 1222 1261 1262 1238 1332 1077 1136 924.3 1069 1123 
15 PARVA 419.8 342.3 1.226 0.0026 428.3 376.3 407.4 398.2 488.8 337.9 335.7 360.4 331.4 346.2 
16 PXN 650.7 537.8 1.210 0.0031 612.0 666.6 678.8 643.8 652.4 514.9 622.5 499.9 494.6 557.6 
17 LAMA3* 5886 4324 1.361 0.0045 5749 5508 6426 5719 6028 4167 3910 3683 4114 5745 
18 THBS1* 601.2 284.8 2.111 0.0057 837.7 800.3 575.4 391.9 400.9 231.7 263.2 256.0 257.5 415.8 
19 ARHGAP26 289.5 156.5 1.850 0.0059 289.1 359.2 266.0 205.7 327.9 97.73 199.4 185.4 181.5 118.5 
20 MICAL2 42.61 35.71 1.193 0.0330 45.03 49.57 43.22 37.64 37.60 36.17 36.72 31.80 33.34 40.52 
21 TNS3 101.9 98.31 1.037 0.7275 98.80 142.8 109.3 104.6 54.12 136.5 81.66 30.05 105.4 138.0 
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Figure 1. PCA analysis of microarray data from OFC and non-OFC cells. The first and second 
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Figure 2. Expression of adhesion genes in palatal keratinocytes analyzed by qPCR. The expression of 
CDH3, ITGB1, JAK1, LAMA3, THBS1 and TNC is significantly down-regulated in OFC keratinocytes vs. 
non-OFC keratinocytes (*, p<0.05). 
 
Immunostaining of tissue samples 
Tissue samples from the palate of OFC and non-OFC individuals were stained 
for β1 integrin and P-cadherin (CDH3) (Figure 3). The β1 integrin subunit was 
mainly expressed in the basal layer of the epithelium and in the basement 
membrane. No obvious differences were observed between OFC and non-OFC 
tissues. P-cadherin was mainly expressed in the upper layers of the epithelium 
excluding the cornified layer (Figure 3). Considerable variation was observed in 
the extent of the expression. No obvious differences were observed between 
OFC and non-OFC tissues. 
  
 
 
Figure 3. (Immuno)staining of palatal tissue samples. Tissue samples from the palatal mucosa of 3 non-
OFC (left) and 4 OFC individuals (right) were sectioned and stained with Heamatoxylin-Eosin (H&E, 
-
the basal layer of the epithelium and the basal membrane. P-cadherin is mainly expressed in the upper 
 
 
Functional validation: scratch assay 
The interrelationship between cell migration and adhesion is complex, as 
effective migration is dependent on the state of cell adhesion. That is, at low 
adhesive state, cytoskeletal forces easily break cell – ECM attachment so that 
cells fail to generate the traction required for locomotion, whereas at high 
adhesive state, cytoskeletal forces are not strong enough to break cell-ECM 
attachment 23. At intermediate adhesive state, however, cytoskeletal forces are 
in balance with adhesion so that traction can be maintained at the front, while it 
can be disrupted at the rear of the cell. This allows effective forward cell body 
movement 23. Thus, cells are unable to migrate if they are either too strongly 
attached or not attached to the ECM.  Therefore, we next sought to investigate 
the impact of the down-regulated genes on the migration of palatal 
keratinocytes using a scratch assay. The migration of OFC keratinocytes (343.6 ± 
29.62 μm) was significantly reduced compared to that of non-OFC keratinocytes 
(503.4 ± 41.81 μm) (Figure 4A). Figure 4C shows the average migration of non-
OFC and OFC keratinocytes. 
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Figure 4. Scratch assay with palatal keratinocytes. A, From left to right; representative of the scratch at 
time point 0; Non-OFC keratinocytes after 16 hours; OFC keratinocytes after 16 hours. B, Measurement 
of migration. The two perpendicular lines represent the scratches that are measured at12 locations (short 
lines). C, The mean migration was calculated as the mean difference between the original width of the 
significantly higher in non-OFC keratinocytes versus OFC keratinocytes (*, p<0.05) 
 
 
Discussion 
To investigate possible deregulated cellular processes in OFC, we performed 
expression microarray analyses with pooled RNA samples from palatal 
keratinocytes from OFC patients and non-OFC individuals. The keratinocytes 
were isolated at about 1.5 years of age of the patients and are obviously not 
identical to the embryonic cells that took part in the fusion process. However, 
we assume that the postnatal cells still contain some (epi)genetic traits that 
have contributed to the aetiology of clefting. This is corroborated by previous 
studies in palatal fibroblasts from patients showing remarkable differences in 
gene expression compared to fibroblasts from control subjects 13-15. PCA of the 
microarray data showed a clear difference in gene expression between the two 
cell types. GO analysis of the expression data revealed differential expression of 
genes involved in adhesion and migration between OFC and non-OFC 
keratinocytes. These data were then validated with qPCR expression analysis of 
individual cell lines. Finally, a scratch assay was performed to confirm the 
functional relevance of these findings. We found that a large part of the 
differentially expressed genes was linked to β1 integrin signalling and other 
pathways related to adhesion and migration. 
Among the differentially regulated genes, several genes were related to the β1 
integrin signalling pathway (ITGB1, ITGA3, ITGB4, LAMA3, LAMC1, THBS1 and 
TNC). Immunostaining showed that the β1 integrin subunit was similarly 
expressed in the basal layer of the epithelium in both OFC and non-OFC tissue 
samples. The gene expression of the integrin subunit β1 was significantly down-
regulated in OFC keratinocytes. Several β1 integrins such as the α2β1, α3β1 and 
α9β1 integrins are strongly expressed in basal keratinocytes and are involved in 
adhesion to the basal lamina 24. Moreover, the ablation of β1 integrin in mouse 
epidermal keratinocytes strongly impairs their migration 25. In addition, the 
expression of the integrin α3 subunit was slightly reduced in the microarray 
analysis. The integrin α3β1 regulates cell polarization and lamellipodia 
formation during keratinocyte migration 26. This integrin binds to laminin 332, a 
major component of hemidesmosomes, which activates the focal adhesion 
kinase (FAK)/src pathway and the downstream Rac1 pathway 26. The latter 
regulates polarization and lamellipodia formation during migration 27. 
Interestingly, the expression of the laminin α3 subunit was also significantly 
reduced in OFC keratinocytes, which might impair laminin 332 function 28. The 
expression of the laminin γ1 subunit was, however, upregulated in OFC 
keratinocytes. Laminin γ1 is a component of laminin 111 which is essential for 
basement membrane formation. Basement membrane formation is regulated by 
β1 integrin signalling 29. Since the expression of the β1 integrin was significantly 
reduced in OFC keratinocytes, basement membrane formation might be 
disturbed. The integrin α9β1 is known to bind to thrombospondin 1 and tenascin 
C, both of which are significantly reduced in OFC keratinocytes. Tenascin C is 
strongly expressed in migrating keratinocytes at the edge of a wound, while 
thrombospondin maintains the adhesion of basal keratinocytes to the basal 
lamina 30, 31. The above data strongly indicate that adhesion to and migration 
over the basal lamina is impaired in OFC keratinocytes. 
Further evidence supporting the impairment of adhesion and migration in OFC 
keratinocytes comes from the differential regulation of the cadherin-related 
genes CDH3, JAK1 and MLLT4. P-cadherin immunostaining was similar in OFC 
and non-OFC tissue samples. The significantly reduced expression of CDH3 in 
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isolated OFC keratinocytes might impair intercellular adhesion and force 
transmission as well as polarization and lamellipodia formation. The latter 
processes are regulated through activation of the Cdc42 pathway 32-34. 
Interestingly, the expression of JAK1 was also significantly down-regulated in 
OFC keratinocytes. Interaction of cadherins with the EGFR-activated 
JAK1/STAT3 signalling pathway regulates actomyosin contractility which is 
essential for cell migration 35-37. Reduced expression of JAK1 might hamper the 
activation of the JAK1/STAT3 signalling and might result in reduced adhesion 
and migration of OFC keratinocytes. In addition, the expression of MLLT4 was 
reduced in OFC keratinocytes. Afadin 1 is an actin filament-binding protein that 
binds to nectin, an immunoglobulin-like cell adhesion molecule which is part of 
AJs together with cadherins 38. A reduced expression of afadin 1 might disturb AJ 
formation. In fact, a mutation in nectin 1 (PVRL1) causes an autosomal recessive 
ectodermal dysplasia (CLPED1) characterized by OFC, syndactyly, and 
ectodermal dysplasia 39. The remaining down-regulated genes are either 
involved in formation of the focal adhesion complex (PXN, PARVA and FBLIM1), 
or the hemidesmosome (DST and ITGB4). Two other genes are involved in actin 
organisation (MICAL2) and the activation of keratinocyte migration (EGFR). All 
of the abovementioned genes are involved in the regulation of adhesion and 
migration of keratinocytes. Hence, reduced expression of these genes impairs 
the adhesion and migration of OFC keratinocytes, which is also confirmed by 
the scratch assay. 
In conclusion, here we show that adhesion and migration programs are 
impaired in OFC keratinocytes, mainly due to reduced β1 integrin signalling and 
the reduced expression of several other genes. Adhesion and migration are 
essential for the correct formation of the secondary palate. Disruption of these 
processes might be induced by gene variations or epigenetic modifications that 
are preserved during embryogenesis and passed on to the postnatal cells. The 
data presented in this study might be highly relevant to the pathogenesis of 
OFC. Yet, further research into the regulation of adhesion and migration is 
crucial to better understand the pathogenesis of OFC and ultimately to improve 
early diagnosis and prevention. 
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reduced in OFC keratinocytes. Afadin 1 is an actin filament-binding protein that 
binds to nectin, an immunoglobulin-like cell adhesion molecule which is part of 
AJs together with cadherins 38. A reduced expression of afadin 1 might disturb AJ 
formation. In fact, a mutation in nectin 1 (PVRL1) causes an autosomal recessive 
ectodermal dysplasia (CLPED1) characterized by OFC, syndactyly, and 
ectodermal dysplasia 39. The remaining down-regulated genes are either 
involved in formation of the focal adhesion complex (PXN, PARVA and FBLIM1), 
or the hemidesmosome (DST and ITGB4). Two other genes are involved in actin 
organisation (MICAL2) and the activation of keratinocyte migration (EGFR). All 
of the abovementioned genes are involved in the regulation of adhesion and 
migration of keratinocytes. Hence, reduced expression of these genes impairs 
the adhesion and migration of OFC keratinocytes, which is also confirmed by 
the scratch assay. 
In conclusion, here we show that adhesion and migration programs are 
impaired in OFC keratinocytes, mainly due to reduced β1 integrin signalling and 
the reduced expression of several other genes. Adhesion and migration are 
essential for the correct formation of the secondary palate. Disruption of these 
processes might be induced by gene variations or epigenetic modifications that 
are preserved during embryogenesis and passed on to the postnatal cells. The 
data presented in this study might be highly relevant to the pathogenesis of 
OFC. Yet, further research into the regulation of adhesion and migration is 
crucial to better understand the pathogenesis of OFC and ultimately to improve 
early diagnosis and prevention. 
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DST TGAACTGGAAATCGCAAATG TCCTGTTGGTGGTGTCGTAG 
EGFR CGGGCTCTGGAGGAAAAG CTTCAAAAGTGCCCAACTGC 
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ITGB4 ATCAGCGTCAGCCTCTCTG CCTTATCCACACGGACACAC 
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Non-syndromic orofacial clefting (OFC) can cause severe functional limitations 
which require complex and long-lasting management. Research in this field 
strives towards a better understanding of the etiopathogenesis of OFC and 
eventually towards improved personalized genetic counselling and prevention. 
Multiple genetic and environmental factors contribute to the etiopathogenesis 
of OFC. Vitamin A, more specifically its biologically active derivative retinoic 
acid (RA), is one of the major regulators of embryonic development and 
differentiation. Thus, RA is closely related to the etiopathogenesis of congenital 
birth defects including OFC. We hypothesized that RA signalling might be 
disturbed in OFC patients which may contribute to OFC. Hence, the main 
objective of this thesis was to investigate the effects of RA on oral keratinocytes 
in order to identify potential RA-related mechanisms in the pathogenesis of 
OFC. For this purpose, we used palatal keratinocytes obtained from individuals 
with and without OFC, and gingival keratinocytes from young adults. In this 
final chapter, we discuss our major findings, their implications as well as 
perspectives for further research. 
 
Effects of RA on oral keratinocyte functions 
For the past three decades, RA has mainly been studied as a therapeutic agent 
for several skin disorders such as acne and psoriasis 1, and more recently also for 
cancer prevention and treatment 2. In relation to this, the effects of RA on 
epidermal keratinocytes and cancer cells have been studied in detail. However, 
the effects of RA on oral keratinocytes are less known. The studies in this thesis 
present novel insights into RA-related mechanisms in oral keratinocyte 
functions such as proliferation, differentiation, apoptosis, migration and 
adhesion, which are highly relevant cellular processes during palatal fusion. In 
the initial stage of palatal fusion the midline edge epithelium (MEE) cells 
develop filopodia and lamellipodia, and start to express adhesion molecules. 
Upon adhesion, the MEE of the opposing shelves form the midline epithelial 
seam (MES). Subsequently, the MES degenerates to allow mesenchymal 
continuity across the secondary palate. Thus, correct functioning of embryonic 
palatal epithelial cells is crucial for palatal development. Using human postnatal 
oral keratinocytes, we aimed to study the effects of RA in oral epithelial cells 
and thus obtain indications on possible RA-related cellular and molecular 
mechanisms in OFC. We show that RA inhibits proliferation and differentiation, 
and induces apoptosis. Moreover, we found that adhesion and migration 
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programs are deregulated in OFC palatal keratinocytes. In the next sections, we 
discuss our main findings in more detail. 
 
Proliferation and Differentiation 
Prior to palatal shelf adhesion, MEE cells stop to proliferate 3 and start to 
differentiate into bulging cells with filopodia 4, 5. Differentiated MEE cells 
develop lamellipodia-like large cellular protrusions that bridge with MEE cells 
from the opposing palatal shelf 6. Therefore, firstly, we analyse the effect of RA 
on proliferation of palatal keratinocytes. In Chapter 3, we observed that RA 
significantly reduces the proliferation of both OFC and non-OFC palatal 
keratinocytes. Interestingly, in cultured human epidermal keratinocytes RA can 
either stimulate 7-9 or inhibit 8, 10, 11 proliferation. The inconsistency is likely 
caused by differences in cell origin, their metabolic state, or the culture 
conditions 8, 12, 13. In Chapter 4, we show that RA significantly down-regulates 
differentiation genes in oral keratinocytes at the transcriptional level. Consistent 
with our data, RA has been repeatedly shown to inhibit human epidermal 
keratinocyte differentiation in vitro 7, 14. In addition, RA reduces differentiation 
in cultured mouse and rat oral keratinocytes 15-17. Previously, RA has also been 
shown to disrupt MEE differentiation 18 and filopodia formation 19. Lamellipodia 
and filopodia formation is regulated by various small GTPases of the Rho family, 
e.g. lamellipodia formation is regulated by Rac1 20, 21 and filopodia formation is 
regulated by Cdc42 21, 22. RA might affect MEE differentiation, and lamellipodia 
and filopodia formation through regulation of Rho GTPases which is the case in 
other cell types 23-25. However, this mechanism needs to be studied more 
extensively in oral epithelial cells. Our findings suggest that aberrant RA 
signalling might disturb MEE differentiation, thus might compromise palatal 
shelf adhesion.  
 
Apoptosis 
Initial adhesion of the palatal shelves results in the fusion of the opposing MEE 
and formation of the midline epithelial seam (MES). Subsequently, the MES 
degenerates to achieve mesenchymal confluence across the palate 26. The exact 
mechanism of MES degeneration is still controversial, however, growing 
evidence supports a major role for apoptosis 27, 28. In Chapter 4, we show that RA 
5 
 
induces the expression of pro-apoptotic genes. Consistent with our results, RA 
has been shown to induce apoptosis in cultured human and mouse epidermal 
keratinocytes 7, 29-31. Interestingly, in mouse embryos and in cultured mouse 
palatal shelves, RA inhibits MES apoptosis 18, 32-34. This differential effect of RA 
could arise from differential interaction of RA receptors with other co-
regulatory genes or pathways in a certain cell type 35. In fact, TGFβ signalling 
which is a major regulator of apoptosis, is induced by RA in human oral 
keratinocytes (Chapter 4), whereas it is suppressed by RA in mouse MES cells 33. 
This indicates that RA regulates the apoptotic dynamics in a cell type-specific 
manner through a complex crosstalk with other co-regulatory molecules.  
 
Migration  
Next to apoptosis, migration also seems to contribute to MES disintegration. 
Following adhesion, MES cells have been shown to migrate to the epithelium at 
the oral or nasal side of the palate 6, 36. In Chapter 5, we show that cell-to-cell as 
well as cell-to-ECM adhesion seems to be deregulated in OFC palatal 
keratinocytes. Cell-to-cell and cell-to-ECM adhesion is an essential component 
of directional cell migration 37, 38. Thus, a deregulated adhesion program can 
lead to impaired migration of OFC keratinocytes. Indeed, in Chapter 5, we show 
that migration is significantly reduced in OFC keratinocytes. Together, the 
findings from Chapter 4 and 5 suggest RA involvement in the regulation of 
adhesion and migration, and a deregulated adhesion and migration program in 
OFC keratinocytes.  
 
RA-p63 crosstalk 
Interestingly, in Chapter 3 and 4, we consistently observed that the expression 
of TP63 encoding the transcription factor p63 is more significantly down-
regulated by RA in OFC cells as compared to non-OFC cells. This suggests that 
p63 expression is more sensitive to RA in OFC cells than in non-OFC cells. 
Mutations in TP63 give rise to syndromic forms of OFC in humans 39. p63 is the 
master regulator of epithelial development and differentiation 40. In palatal 
fusion, p63  orchestrates the adhesion of the opposing MEE and maintains the 
proliferative potential of the basal layer of the MEE 41. Thus, down-regulated 
TP63 expression by RA might disturb proliferation, differentiation and adhesion 
in oral keratinocytes. Consistent with our data, RA down-regulates the 
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mechanism of MES degeneration is still controversial, however, growing 
evidence supports a major role for apoptosis 27, 28. In Chapter 4, we show that RA 
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induces the expression of pro-apoptotic genes. Consistent with our results, RA 
has been shown to induce apoptosis in cultured human and mouse epidermal 
keratinocytes 7, 29-31. Interestingly, in mouse embryos and in cultured mouse 
palatal shelves, RA inhibits MES apoptosis 18, 32-34. This differential effect of RA 
could arise from differential interaction of RA receptors with other co-
regulatory genes or pathways in a certain cell type 35. In fact, TGFβ signalling 
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Migration  
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findings from Chapter 4 and 5 suggest RA involvement in the regulation of 
adhesion and migration, and a deregulated adhesion and migration program in 
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RA-p63 crosstalk 
Interestingly, in Chapter 3 and 4, we consistently observed that the expression 
of TP63 encoding the transcription factor p63 is more significantly down-
regulated by RA in OFC cells as compared to non-OFC cells. This suggests that 
p63 expression is more sensitive to RA in OFC cells than in non-OFC cells. 
Mutations in TP63 give rise to syndromic forms of OFC in humans 39. p63 is the 
master regulator of epithelial development and differentiation 40. In palatal 
fusion, p63  orchestrates the adhesion of the opposing MEE and maintains the 
proliferative potential of the basal layer of the MEE 41. Thus, down-regulated 
TP63 expression by RA might disturb proliferation, differentiation and adhesion 
in oral keratinocytes. Consistent with our data, RA down-regulates the 
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expression of TP63 in immortalized nasopharyngeal epithelial cells 42. However, 
RA has also been shown to up-regulate TP63 expression in other cell types 43. 
These different observations may be explained by the fact that other isoforms of 
p63 have been investigated in these reports, as p63 is known to have many 
different isoforms 44, 45. Furthermore, p63 and RA interaction seems to be rather 
complex. p63 has been shown to up-regulate retinal short-chain 
dehydrogenase/reductase (retSDR1) 46 which suggests that p63 induces RA 
biosynthesis. In addition, an RXRA motif has been found in TP63 binding site in 
epidermal keratinocytes 47, suggesting co-regulation of target genes  by p63 and 
RAR/RXR. In addition to these studies, our data suggest a crosstalk between RA 
and p63 in oral keratinocytes.  Whether this is relevant to the disease 
mechanism of OFC has yet to be investigated. 
 
Strengths and limitations of the study 
The studies conducted here are some of the few to investigate the effects of RA 
on human oral epithelial cells. Furthermore, these are the first to study RA-
related mechanisms using oral keratinocytes derived from OFC patients. 
Generally, studies on molecular mechanisms in OFC are conducted in mice. 
Ideally, we would have preferred to use human embryonic keratinocytes from 
the palate. However, as these cells are difficult to obtain, we used human 
postnatal oral keratinocytes from individuals with and without OFC. This 
offered us the opportunity to study cellular and molecular mechanisms relevant 
to OFC in patient cells.  
During embryonic development, gene expression patterns may be changed 
through epigenetic modifications which are maintained in postnatal life 48. 
Therefore, postnatal oral keratinocytes might carry epigenetic marks of 
environmental influences that occurred during development. Therefore, the 
response of postnatal palatal keratinocytes derived from OFC patients to RA 
might partly mimic that of  keratinocytes from the embryonic palate. 
A limitation of our studies is the small number of cell lines from patient and 
control palatal keratinocytes. These cell lines are derived from patients with 
various OFC subtypes. Due to the invasiveness of the tissue sampling, we could 
only obtain  a limited amount of keratinocyte cell lines. For this reason, the cells 
were not stratified into specific OFC subtypes. This might limit the implications 
of our data for various OFC subtypes, as clefts of the lip and the primary palate 
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might have distinct genetic and embryological origin from clefts of the 
secondary palate 49, 50. It would therefore be useful to extend these studies using 
a larger number of cell lines stratified into OFC subtypes. This might also give 
more information on possible specific molecular mechanisms in distinct OFC 
subtypes. 
 
Future perspectives  
This work yields interesting insights about the effects of RA on human oral 
keratinocytes. We found indications that RA affects key cellular processes 
relevant for palatogenesis such as proliferation, differentiation, apoptosis, 
adhesion and migration. We observed that RA deregulates the expression of 
several OFC-related genes including PHC2, SOX4, SOX9 and GRHL3. Based on 
these data, RA-related pathogenic mechanisms could be further investigated in 
vivo using knock-out mouse models for OFC-related genes.  
We observed that the expression of TP63 in OFC cells is more sensitive to RA. 
As discussed earlier, RA and TP63 seem to interact with each other through a 
complex mechanism which is still not well-understood. Considering that 
mutations in TP63 as well as aberrant RA signalling can cause OFC, RA-p63 
crosstalk may be crucial in palate development. Given the evidence from our in 
vitro studies, further research should focus on elucidation of this crosstalk using 
in vitro and in vivo models. It would be interesting to investigate RA responsive 
elements  in the proximity of TP63, as well as p63 binding sites in the proximity 
of important RA metabolic genes, and their role in palate development. This 
could provide valuable information on RA-p63 crosstalk in the etiopathogenesis 
of OFC.  
We found that adhesion and migration programs are deregulated at the gene 
expression level in palatal keratinocytes derived from OFC patients. 
Furthermore, we showed that RA affects the expression of OFC-related genes 
involved in adhesion and migration. Therefore, it would be interesting to 
investigate the effect of RA on palatal shelf fusion in cultured mouse palatal 
shelves and expression of these genes during this process. A recent study with 
live imaging showed that following adhesion, the MES disappears through 
migration of the MES cells to the oral and nasal surfaces of the palate 6. It would 
be very interesting to analyse the effect of RA on the fusion of cultured palatal 
shelves under live imaging. This would provide useful information on how RA 
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affects cellular mechanisms such as lamellipodia and filopodia formation, 
migration and apoptosis during palatal fusion. 
The effects of RA are mediated by RARα, RARγ1 and RXR receptors in oral 
epithelium 51. Any mutation or variation in RA receptors might induce 
overactivation or inactivation of RA signalling in the developing palate, which 
can contribute to OFC. Therefore, it would be interesting to investigate which 
receptors mediate RA signalling during palatogenesis. In addition, further 
research into mutations or variations in other components of RA signalling (e.g. 
RA synthesizing and degrading enzymes, binding proteins, and response 
elements) will contribute to understanding of RA-related mechanisms in OFC.  
It is obvious from our data that RA affects critical cellular processes in oral 
keratinocytes which are highly relevant to palate development.  Accordingly, 
correct RA synthesis and signalling is crucial for palatogenesis. Variations in the 
genes encoding metabolic enzymes, transport proteins, receptors and other  
components can alter RA signalling. For instance, polymorphisms in RA 
metabolizing enzymes are linked to congenital defects in the neural tube and 
the heart 52. Previously, polymorphisms in folate metabolism have been linked 
to OFC 53. Similar polymorphisms in RA metabolism might influence RA 
signalling and increase the risk for OFC. Further unraveling of the role of RA in 
palatogenesis and in OFC will contribute to personalized genetic counselling 
and prevention of this disorder. 
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Summary 
Retinoic acid (RA), the active derivative of vitamin A, is associated with 
orofacial clefting (OFC) through a mechanism which is not completely clear. 
Therefore, the major goal of this thesis was to investigate RA-related 
mechanisms in oral keratinocytes and thus to try elucidate the possible role of 
RA in the etiopathogenesis of OFC. We start in Chapter 1 with a the general 
introduction to the epidemiology, subtypes, and cellular and molecular 
mechanisms of OFC. We shortly discuss several causative genetic mutations 
underlying syndromic forms of OFC and then focus on the regulatory genes and 
signalling pathways mainly associated to non-syndromic OFC. We then discuss 
the impact of environmental risk factors combined with genetic background on 
the aetiology of OFC. Finally, we present the rationale and the aims of this 
thesis. 
In Chapter 2, we first present an overview of RA biosynthesis and signalling. 
Subsequently, we discuss the  role of RA in the development of the epidermis, 
the limbs and the secondary palate which share common regulatory pathways. 
In conjunction with other regulatory molecules, RA promotes the development 
of the epithelium from the ectoderm. In the limbs, RA signalling  initiates limb 
bud formation, digit separation and regulates chondrogenesis and osteogenesis. 
In the secondary palate, RA is a key factor for mesenchymal cell proliferation 
during palatal shelf outgrowth and elevation, and for differentiation and 
apoptosis of the palatal epithelium during palatal fusion. In addition, RA is also 
involved in bone formation in the hard palate. Finally, we discuss recent 
evidence on polymorphisms in the genes encoding proteins involved in RA 
biosynthesis and signalling which might affect RA levels and activity within 
embryonic tissues.  We conclude that correct spatiotemporal RA biosynthesis 
and activity is crucial for embryonic development and that disturbances may 
lead to congenital diseases such as OFC.  
In Chapter 3, we investigated the effects of RA on the proliferation and gene 
expression in palatal keratinocytes obtained from OFC and non-OFC patients. 
We observed that RA reduces palatal keratinocyte proliferation in a dose 
dependent-manner. We also observed a large inter-individual variation in 
response to RA, but no significant difference  between OFC and non-OFC 
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palatal keratinocytes. In addition, gene expression analyses show that RA 
downregulates the expression of early differentiation genes. 
In Chapter 4, we analyzed the effect of RA on the expression of OFC- related 
genes in oral keratinocytes derived from the gingiva and the palate. Gene 
ontology analysis of the differentially expressed genes demonstrates a significant 
enrichment for genes involved in angiogenesis, apoptosis and keratinocyte 
differentiation. Interestingly, the fraction of affected OFC-related genes was 
significantly higher than the fraction of total protein-coding genes. 
Deregulation of these genes by RA seems to induce apoptosis and inhibit 
differentiation, which might be relevant to the pathogenesis of OFC. In 
addition, RA seems to affect proliferation, adhesion and migration at the gene 
expression level which has to be further investigated using functional analyses.  
In Chapter 5, we hypothesized that the expression of genes related to key 
cellular processes for palate development such as proliferation, differentiation, 
adhesion, migration and apoptosis might be deregulated in keratinocytes 
derived from OFC patients. For this purpose, we performed genome-wide 
expression analysis on palatal keratinocytes derived from OFC patients and non-
OFC controls. This analysis showed a clear difference in gene expression 
between the two cell types. Gene ontology analysis revealed a significant 
enrichment for the genes involved in adhesion and migration. Using 
bioinformatic techniques we identified 21 adhesion- and migration-related 
genes, all of which were downregulated in OFC keratinocytes. Finally, a scratch 
assay demonstrated significantly reduced migration of OFC keratinocytes as 
compared to non-OFC keratinocytes. This indicates that adhesion and 
migration programs are deregulated in OFC keratinocytes, which might be 
relevant to OFC pathogenesis.  
Chapter 6 provides a general discussion of the main findings and implications, 
and future perspectives of the research conducted within this thesis.  
  
4 
 
Samenvatting 
Retinolzuur, het actieve derivaat van vitamine A, wordt geassocieerd met schisis 
maar het mechanisme is nog  niet helemaal duidelijk. Daarom was het 
hoofddoel van dit proefschrift om retinolzuur-gerelateerde mechanismen in 
orale keratinocyten te onderzoeken en zo de mogelijke rol van RA in de 
etiopathogenese van schisis op te helderen. We beginnen in Hoofdstuk 1 met 
een algemene inleiding in de epidemiologie en klinische subtypes van schisis, en 
een overzicht van de cellulaire en moleculaire mechanismen die een rol spelen 
bij schisis. We bespreken kort enkele causatieve genetische mutaties die aan de 
basis liggen van syndromale schisis en richten ons vervolgens op de regulerende 
genen en signaalroutes die geassocieerd zijn met niet-syndromale schisis. 
Vervolgens bespreken we de rol van omgevingsfactoren in combinatie met 
genetische factoren bij de etiologie van niet-syndromale schisis. Ten slotte 
presenteren we de  doelstellingen van dit proefschrift. 
In Hoofdstuk 2 presenteren we eerst een overzicht van de retinolzuur 
biosynthese en signalering. Vervolgens bespreken we de rol van retinolzuur in 
de ontwikkeling van de epidermis, de ledematen en het secundaire gehemelte 
die  regulerende routes delen. In combinatie met andere regulerende moleculen 
coördineert  retinolzuur de ontwikkeling van  ectodermale weefsels. Retinolzuur 
initieert de vorming van de ledemaatknoppen, vingerseparatie en reguleert 
chondrogenese en osteogenese in de groeiende ledematen. In het secundaire 
gehemelte is retinolzuur een sleutelfactor voor de mesenchymale celproliferatie 
tijdens de uitgroei en orientatie van de twee delen van het palatum, en ook voor 
de differentiatie en apoptose van het palatinale epitheel tijdens de  fusie. 
Daarnaast is retinolzuur ook betrokken bij de regulatie van botvorming in het 
harde gehemelte. Ten slotte, bespreken we recente data over polymorfismen in 
de genen voor eiwitten die betrokken zijn bij de biosynthese en signalering van 
retinolzuur. Veranderingen in deze eiwitten kunnen de concentratie van 
retinolzuur in embryonale weefsels beïnvloeden. We concluderen dat een 
correcte aanmaak en afbraak van retinolzuur cruciaal is voor de embryonale 
ontwikkeling en dat verstoringen daarin kunnen leiden tot aangeboren 
aandoeningen zoals schisis.  
In Hoofdstuk 3 onderzochten we de effecten van retinolzuur op de proliferatie 
en genexpressie van palatinale keratinocyten verkregen van patiënten met en 
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zonder schisis. We hebben vastgesteld dat retinolzuur de proliferatie remt van 
palatale keratinocyten op een dosisafhankelijke manier. We observeerden ook 
een grote inter-individuele variatie in de reactie op retinolzuur, maar geen 
verschil tussen palatinale keratinocyten van patiënten met en zonder schisis. 
Bovendien zagen we dat retinolzuur de expressie van vroege differentiatiegenen 
verlaagde.  
In Hoofdstuk 4 analyseerden we het effect van retinolzuur op de expressie van 
schisis-gerelateerde genen in orale keratinocyten van de gingiva en het 
gehemelte. Een analyse van de beïnvloedde  genen liet een verrijking zien van 
genen die betrokken zijn bij de angiogenese, apoptose en differentiatie van 
keratinocyten. Interessant is dat de  schisis-gerelateerde genen significant 
sterker beïnvloed werden dan de andere eiwit-coderende genen. De 
beïnvloeding van deze genen door retinolzuur lijkt apoptose te veroorzaken en 
differentiatie te remmen, wat mogelijk relevant is voor de pathogenese van 
schisis. Bovendien lijkt retinolzuur de proliferatie, adhesie en migratie te 
beïnvloeden op basis van de analyse van genexpressie. Dit moet verder worden 
onderzocht met behulp van functionele analyses. 
In Hoofdstuk 5 zijn we uitgegaan van de hypothese dat de expressie van genen 
gerelateerd aan cellulaire processen, zoals proliferatie, differentiatie, adhesie, 
migratie en apoptose, verstoord is in keratinocyten afkomstig van schisis-
patiënten. Voor dit doel voerden we een genoombrede expressie-analyse uit op 
palatinale keratinocyten van schisis-patiënten en controles. Deze analyse 
toonde een duidelijk verschil in genexpressie tussen de twee celtypen. De 
expressie-analyse liet een significante verrijking zien van genen die betrokken 
zijn bij adhesie en migratie. Met behulp van bioinformatica-technieken 
identificeerden we 21 adhesie- en migratiegerelateerde genen, waarvan de 
expressie was verlaagd in keratinocyten van schisis-patiënten. Tenslotte vonden 
we een significant verminderde migratie van schisis-keratinocyten in 
vergelijking met controle-keratinocyten. Dit geeft aan dat adhesie en migratie 
waarschijnlijk verstoord zijn in schisis-keratinocyten, wat relevant kan zijn voor 
de pathogenese van schisis. 
Hoofdstuk 6 biedt een algemene discussie van de belangrijkste bevindingen en 
de mogelijke implicaties daarvan, en een perspectieven voor nieuw onderzoek 
op dit terrein. 
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“A life without love is of no account. Don’t ask yourself what kind of love you 
should seek, spiritual or material, divine or mundane, Eastern or Western. 
Divisions only lead to more divisions. Love has no labels, no definitions. It is what 
it is, pure and simple. Love is the water of life. And a lover is a soul of fire! The 
universe turns differently when fire loves water.”  
Shams Tabrizi (The Forty Rules of Love by Elif Shafak) 
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